<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>Annals of Surgical Oncology via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Annals of Surgical Oncology' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Annals+of+Surgical+Oncology&t=Annals+of+Surgical+Oncology&s=Search&f=source]]></link>
        <lastBuildDate>Wed, 08 Feb 2012 08:41:15 +0100</lastBuildDate>
        <item>
            <title>Concepts of Regional Therapies for Advanced Malignancy</title>
            <link>http://www.medworm.com/index.php?rid=5666738&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fdu542278736824g7%2F</link>
            <description>Content Type Journal ArticleCategory Regional Cancer TherapiesPages 1-2DOI 10.1245/s10434-012-2243-4Authors
		T. Clark Gamblin, Division of Surgical Oncology, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USAH. Richard Alexander, Department of Surgery, University of Maryland, Baltimore, MD, USARobert Edwards, Division of Gynecologic Oncology, University of Pittsburgh, Pittsburgh, PA, USADavid L. Bartlett, Division of Surgical Oncology, Department of Surgery, University of Pittsburgh, Pittsburgh, PA, USA
	

	
		Journal Annals of Surgical OncologyOnline ISSN 1534-4681Print ISSN 1068-9265 (Source: Annals of Surgical Oncology)</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5666738</comments>
            <pubDate>Fri, 03 Feb 2012 07:21:22 +0100</pubDate>
            <guid isPermaLink="false">5666738</guid>        </item>
        <item>
            <title>Quality of Life Outcomes after Isolated Limb Infusion</title>
            <link>http://www.medworm.com/index.php?rid=5666740&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fcx64723827071q28%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;ILI for melanoma and Merkel cell carcinoma is associated with postprocedure symptoms in most patients, most commonly edema,
 color change, and numbness. At last follow-up, no ILI patients had residual functional impairment in the treated limb.
 
 
 
 
	Content Type Journal ArticleCategory Regional Cancer TherapiesPages 1-6DOI 10.1245/s10434-012-2239-0Authors
		Rebecca J. McClaine, Department of Surgery, University of Cincinnati, Cincinnati, OH, USAJoseph S. Giglia, Department of Surgery, University of Cincinnati, Cincinnati, OH, USASyed A. Ahmad, Department of Surgery, University of Cincinnati, Cincinnati, OH, USAStephanie J. McCoy, Department of Surgery, University of Cincinnati, Cincinnati, OH, USAJeffrey J. Sussman, Department of Surgery, University of Cincinnati,...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5666740</comments>
            <pubDate>Fri, 03 Feb 2012 07:21:21 +0100</pubDate>
            <guid isPermaLink="false">5666740</guid>        </item>
        <item>
            <title>Chronic Anti-inflammatory Drug Therapy Inhibits Gel-Forming Mucin Production in a Murine Xenograft Model of Human Pseudomyxoma Peritonei</title>
            <link>http://www.medworm.com/index.php?rid=5666739&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fll5534h124472831%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Inflammatory mediators are known to regulate mucin production and may promote overexpression of MUC2 by neoplastic cells with
 goblet cell phenotype in PMP. Anti-inflammatory drugs, dexamethasone and Celebrex, could inhibit extracellular mucin production
 in PMP by targeting inflammatory cascades and, therefore, may decrease compressive symptoms, increase the disease-free interval,
 and reduce the extent or frequency of morbid cytoreductive surgeries.
 
 
 
 
	Content Type Journal ArticleCategory Regional Cancer TherapiesPages 1-8DOI 10.1245/s10434-012-2242-5Authors
		Haroon Asif Choudry, Division of Surgical Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, USAArun Mavanur, Division of Surgical Oncology, University of Pittsburgh Medical Center, Pitt...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5666739</comments>
            <pubDate>Fri, 03 Feb 2012 07:21:21 +0100</pubDate>
            <guid isPermaLink="false">5666739</guid>        </item>
        <item>
            <title>Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Peritoneal Sarcomatosis</title>
            <link>http://www.medworm.com/index.php?rid=5666742&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb8577l5466776lm1%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;A complete cytoreduction and low PCI score appear to be important factors in considering CRS and HIPEC for patients with peritoneal
 sarcomatosis.
 
 
 
 
	Content Type Journal ArticleCategory Regional Cancer TherapiesPages 1-6DOI 10.1245/s10434-012-2240-7Authors
		George I. Salti, Division of Surgical Oncology, Department of Surgery, The University of Illinois at Chicago, Chicago, IL, USALuay Ailabouni, Division of Surgical Oncology, Department of Surgery, The University of Illinois at Chicago, Chicago, IL, USASamir Undevia, Division of Hematology and Oncology, The University of Chicago, Chicago, IL, USA
	

	
		Journal Annals of Surgical OncologyOnline ISSN 1534-4681Print ISSN 1068-9265 (Source: Annals of Surgical Oncology)</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5666742</comments>
            <pubDate>Fri, 03 Feb 2012 07:21:20 +0100</pubDate>
            <guid isPermaLink="false">5666742</guid>        </item>
        <item>
            <title>Aggressive Management of Peritoneal Carcinomatosis from Mucinous Appendiceal Neoplasms</title>
            <link>http://www.medworm.com/index.php?rid=5666741&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk060j86778754149%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Aggressive management of PC from mucinous appendiceal neoplasms, by experienced surgeons, to achieve complete cytoreduction
 provides long-term survival with low major morbidity.
 
 
 
 
	Content Type Journal ArticleCategory Regional Cancer TherapiesPages 1-8DOI 10.1245/s10434-012-2241-6Authors
		Frances Austin, Division of Surgical Oncology, University of Pittsburgh, Pittsburgh, PA, USAArun Mavanur, Division of Surgical Oncology, University of Pittsburgh, Pittsburgh, PA, USAMagesh Sathaiah, Division of Surgical Oncology, University of Pittsburgh, Pittsburgh, PA, USAJennifer Steel, Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA, USADiana Lenzner, Biostatistics Facility, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USALekshmi Ramali...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5666741</comments>
            <pubDate>Fri, 03 Feb 2012 07:21:20 +0100</pubDate>
            <guid isPermaLink="false">5666741</guid>        </item>
        <item>
            <title>Importance of Histologic Subtype in the Staging of Appendiceal Tumors</title>
            <link>http://www.medworm.com/index.php?rid=5666743&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft272570888v66253%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Histologic subtype is an important predictor of disease-specific survival and overall survival in patients with appendiceal
 neoplasms. Addition of the histologic subtype to the TNM staging is simple and may improve prognostication.
 
 
 
 
	Content Type Journal ArticleCategory Regional Cancer TherapiesPages 1-7DOI 10.1245/s10434-012-2238-1Authors
		Kiran K. Turaga, Division of Surgical Oncology, Medical College of Wisconsin, Milwaukee, WI, USASam G. Pappas, Division of Surgical Oncology, Medical College of Wisconsin, Milwaukee, WI, USAT. Clark Gamblin, Division of Surgical Oncology, Medical College of Wisconsin, Milwaukee, WI, USA
	

	
		Journal Annals of Surgical OncologyOnline ISSN 1534-4681Print ISSN 1068-9265 (Source: Annals of Surgical Oncology)</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5666743</comments>
            <pubDate>Fri, 03 Feb 2012 07:21:18 +0100</pubDate>
            <guid isPermaLink="false">5666743</guid>        </item>
        <item>
            <title>Combined Diffusion-Weighted and Gadolinium-Enhanced MRI Can Accurately Predict the Peritoneal Cancer Index Preoperatively in Patients Being Considered for Cytoreductive Surgical Procedures</title>
            <link>http://www.medworm.com/index.php?rid=5666745&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr1hxnuq203u77673%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Combined diffusion-weighted and gadolinium-enhanced peritoneal MRI accurately predicts the PCI before surgery in patients
 undergoing evaluation for cytoreductive surgery.
 
 
 
 
	Content Type Journal ArticleCategory Regional Cancer TherapiesPages 1-8DOI 10.1245/s10434-012-2236-3Authors
		Russell N. Low, Department of Radiology, Sharp Memorial Hospital, San Diego, CA, USARobert M. Barone, Department of Surgical Oncology, Sharp Memorial Hospital, San Diego, CA, USA
	

	
		Journal Annals of Surgical OncologyOnline ISSN 1534-4681Print ISSN 1068-9265 (Source: Annals of Surgical Oncology)</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5666745</comments>
            <pubDate>Fri, 03 Feb 2012 07:21:17 +0100</pubDate>
            <guid isPermaLink="false">5666745</guid>        </item>
        <item>
            <title>Cytoreductive Surgery with Selective Versus Complete Parietal Peritonectomy Followed by Hyperthermic Intraperitoneal Chemotherapy in Patients with Diffuse Malignant Peritoneal Mesothelioma: A Controlled Study</title>
            <link>http://www.medworm.com/index.php?rid=5666744&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F25365847752600k3%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;CPP improved survival in patients with DMPM undergoing combined treatment. This information may contribute to standardize
 surgical options for DMPM and other peritoneal malignancies.
 
 
 
 
	Content Type Journal ArticleCategory Regional Cancer TherapiesPages 1-9DOI 10.1245/s10434-012-2237-2Authors
		Dario Baratti, Department of Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Milan, ItalyShigeki Kusamura, Department of Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Milan, ItalyAntonello Domenico Cabras, Department of Pathology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, ItalyMarcello Deraco, Department of Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
	

	
		Journal Annals of Surgical OncologyOnline ISSN 1534-4681Print ISSN 1068...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5666744</comments>
            <pubDate>Fri, 03 Feb 2012 07:21:17 +0100</pubDate>
            <guid isPermaLink="false">5666744</guid>        </item>
        <item>
            <title>Erratum to: The Combination of Surgery and Imatinib in GIST: A Reality for Localized Tumors at High Risk, an Open Issue for Metastatic Ones</title>
            <link>http://www.medworm.com/index.php?rid=5666746&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7j4r164x6jux3414%2F</link>
            <description>Content Type Journal ArticleCategory ErratumPages 1-1DOI 10.1245/s10434-012-2251-4Authors
		Alessandro Gronchi, Department of Surgery, Sarcoma Service, Fondazione IRCCS Istituto Nazionale Tumori, Milan, ItalyChandrajit P. Raut, Department of Surgery, Brigham and Women’s Hospital, Boston, MA, USA
	

	
		Journal Annals of Surgical OncologyOnline ISSN 1534-4681Print ISSN 1068-9265 (Source: Annals of Surgical Oncology)</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5666746</comments>
            <pubDate>Thu, 02 Feb 2012 18:12:39 +0100</pubDate>
            <guid isPermaLink="false">5666746</guid>        </item>
        <item>
            <title>Salvage Hepatectomy for Local Recurrent Hepatocellular Carcinoma After Ablation Therapy</title>
            <link>http://www.medworm.com/index.php?rid=5666747&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx4256r4qt6146531%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The short-term and long-term results of salvage hepatectomy after incomplete percutaneous ablation therapy are equivalent
 to those of primary hepatectomy. Salvage hepatectomy is an acceptable treatment for patients with local recurrence of hepatocellular
 carcinoma after ablation therapy.
 
 
 
 
	Content Type Journal ArticleCategory Hepatobiliary TumorsPages 1-8DOI 10.1245/s10434-012-2220-yAuthors
		Hiroyuki Sugo, Department of Hepatobiliary-Pancreatic Surgery, Juntendo University School of Medicine, Tokyo, JapanYoichi Ishizaki, Department of Hepatobiliary-Pancreatic Surgery, Juntendo University School of Medicine, Tokyo, JapanJiro Yoshimoto, Department of Hepatobiliary-Pancreatic Surgery, Juntendo University School of Medicine, Tokyo, JapanHiroshi Imamura, Departm...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5666747</comments>
            <pubDate>Thu, 02 Feb 2012 18:12:38 +0100</pubDate>
            <guid isPermaLink="false">5666747</guid>        </item>
        <item>
            <title>The Relationship of Lymph Node Evaluation and Colorectal Cancer Survival After Curative Resection: A Multi-Institutional Study</title>
            <link>http://www.medworm.com/index.php?rid=5666748&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fen788871340020q4%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;This study found that the number of lymph nodes retrieved and the number of positive nodes are both important prognostic factors.
 At least a 12-node threshold may be supported as a measure to improve a predictive capacity within individual patients and
 as a quality control parameter of hospital performance.
 
 
 
 
	Content Type Journal ArticleCategory Colorectal CancerPages 1-9DOI 10.1245/s10434-012-2223-8Authors
		Yukihide Kanemitsu, Department of Gastroenterological Surgery, Aichi Cancer Center, Nagoya, JapanKoji Komori, Department of Gastroenterological Surgery, Aichi Cancer Center, Nagoya, JapanSeiji Ishiguro, Department of Gastroenterological Surgery, Aichi Cancer Center, Nagoya, JapanToshiaki Watanabe, Department of Surgery, Teikyo University School of Medici...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5666748</comments>
            <pubDate>Thu, 02 Feb 2012 18:12:37 +0100</pubDate>
            <guid isPermaLink="false">5666748</guid>        </item>
        <item>
            <title>Comparison Between Radical Esophagectomy and Definitive Chemoradiotherapy in Patients with Clinical T1bN0M0 Esophageal Cancer</title>
            <link>http://www.medworm.com/index.php?rid=5666749&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw781w1r0780n4111%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Selection of patients at high risk of pathologic lymph node metastasis is essential when formulating treatment decisions for
 clinical T1bN0M0 esophageal cancers.
 
 
 
 
	Content Type Journal ArticleCategory Gastrointestinal OncologyPages 1-7DOI 10.1245/s10434-012-2231-8Authors
		Masaaki Motoori, Department of Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, JapanMasahiko Yano, Department of Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, JapanRyu Ishihara, Department of Gastrointestinal Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, JapanSachiko Yamamoto, Department of Gastrointestinal Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, JapanYoshifumi K...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5666749</comments>
            <pubDate>Thu, 02 Feb 2012 18:12:36 +0100</pubDate>
            <guid isPermaLink="false">5666749</guid>        </item>
        <item>
            <title>Significance of Lymph Node Capsular Invasion in Esophageal Squamous Cell Carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5659387&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F55545584mg00478x%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;LNCI in ESCC patients is an indicator of distant organ recurrence and a worse prognosis. LNCI could be used as a candidate
 marker for designing more precise staging and therapeutic strategies for ESCC.
 
 
 
 
	Content Type Journal ArticleCategory Gastrointestinal OncologyPages 1-7DOI 10.1245/s10434-012-2232-7Authors
		Makoto Sakai, Department of General Surgical Science, Gunma University, Graduate School of Medicine, Maebashi, JapanShigemasa Suzuki, Department of General Surgical Science, Gunma University, Graduate School of Medicine, Maebashi, JapanAkihiko Sano, Department of General Surgical Science, Gunma University, Graduate School of Medicine, Maebashi, JapanNaritaka Tanaka, Department of General Surgical Science, Gunma University, Graduate School of Medicine,...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5659387</comments>
            <pubDate>Tue, 31 Jan 2012 07:11:04 +0100</pubDate>
            <guid isPermaLink="false">5659387</guid>        </item>
        <item>
            <title>K-ras Mutation is Strongly Associated with Perineural Invasion and Represents an Independent Prognostic Factor of Intrahepatic Cholangiocarcinoma after Hepatectomy</title>
            <link>http://www.medworm.com/index.php?rid=5659389&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl7227t31373p7206%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The prevalence of K-ras mutations in a considerably large cohort of ICC was 22%. K-ras mutation is strongly associated with
 perineural invasion phenotypically. K-ras mutation is an independent prognostic factor of ICC after hepatectomy.
 
 
 
 
	Content Type Journal ArticleCategory Translational Research and BiomarkersPages 1-7DOI 10.1245/s10434-012-2224-7Authors
		Tse-Ching Chen, Department of Pathology, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, TaiwanYi-Yin Jan, Department of Surgery, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, TaiwanTa-Sen Yeh, Department of Pathology, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan
	

	
		Journal Annals of Surgical OncologyOnline ISSN 1534-4681Print ISSN 1068-9265 (Sourc...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5659389</comments>
            <pubDate>Tue, 31 Jan 2012 07:11:03 +0100</pubDate>
            <guid isPermaLink="false">5659389</guid>        </item>
        <item>
            <title>Surgical Management of Melanoma Lung Metastasis: An Analysis of Survival Outcomes in 292 Consecutive Patients</title>
            <link>http://www.medworm.com/index.php?rid=5659388&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Flv16p8g6m1401628%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The results support the role of pulmonary metastasectomy in selected patients with MLM. Patients with small (&amp;lt;2&amp;nbsp;cm) and solitary
 tumors that can be completely resected with a negative margin are most likely to experience prolonged survival.
 
 
 
 
	Content Type Journal ArticleCategory MelanomasPages 1-8DOI 10.1245/s10434-011-2197-yAuthors
		Terence C. Chua, Melanoma Institute Australia, Royal Prince Alfred Hospital, Sydney, NSW, AustraliaRichard A. Scolyer, Melanoma Institute Australia, Royal Prince Alfred Hospital, Sydney, NSW, AustraliaCatherine W. Kennedy, Department of Cardiothoracic Surgery, Royal Prince Alfred Hospital, Sydney, NSW, AustraliaTristan D. Yan, Department of Cardiothoracic Surgery, Royal Prince Alfred Hospital, Sydney, NSW, AustraliaBrian...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5659388</comments>
            <pubDate>Tue, 31 Jan 2012 07:11:03 +0100</pubDate>
            <guid isPermaLink="false">5659388</guid>        </item>
        <item>
            <title>Comparison of Acute Toxicities in Two Primary Chemoradiation Regimens in the Treatment of Advanced Head and Neck Squamous Cell Carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5659391&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk7t43t8586l45317%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;With concurrent radiotherapy, low-dose, single-agent, weekly cisplatin is less likely than higher-dose daily cisplatin plus
 5-fluorouracil provided at the beginning and end of treatment to be associated with ototoxicity. The preliminary data suggest
 at least equivalent efficacy, but longer follow-up is required.
 
 
 
 
	Content Type Journal ArticleCategory Head and Neck OncologyPages 1-8DOI 10.1245/s10434-012-2219-4Authors
		Katherine Y. Fan, Johns Hopkins University School of Medicine, Baltimore, MD, USAHrishikesh Gogineni, Case Western Reserve University School of Medicine, Cleveland, OH, USADavid Zaboli, Johns Hopkins University School of Medicine, Baltimore, MD, USASpencer Lake, Johns Hopkins University School of Medicine, Baltimore, MD, USAMarianna L. Zahurak...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5659391</comments>
            <pubDate>Tue, 31 Jan 2012 07:11:02 +0100</pubDate>
            <guid isPermaLink="false">5659391</guid>        </item>
        <item>
            <title>Has the Survival Rate for Surgically Resected Gastric Gastrointestinal Stromal Tumors Improved in the Tyrosine Kinase Inhibitor Era?</title>
            <link>http://www.medworm.com/index.php?rid=5659390&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu8k89n375nhu0028%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The TKI era is associated with dramatic improvements in OS and DSS for patients with surgically resected gastric GISTs, irrespective
 of stage, tumor size, and extent of operation through 6&amp;nbsp;years of follow-up. It remains unclear, however, whether this survival
 advantage is a change in cure rate or simply a delay in disease progression.
 
 
 
 
	Content Type Journal ArticleCategory Healthcare Policy and OutcomesPages 1-11DOI 10.1245/s10434-012-2222-9Authors
		Felipe E. Pedroso, Department of Surgery, Jefferson Medical College, Philadelphia, PA, USAChandrajit P. Raut, Department of Surgery, Division of Surgical Oncology, Brigham and Women’s Hospital, Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USAHong ...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5659390</comments>
            <pubDate>Tue, 31 Jan 2012 07:11:02 +0100</pubDate>
            <guid isPermaLink="false">5659390</guid>        </item>
        <item>
            <title>Adrenocortical Carcinoma with Intracaval Extension to the Right Atrium: Resection on Cardiopulmonary Bypass</title>
            <link>http://www.medworm.com/index.php?rid=5647027&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F683224282208654k%2F</link>
            <description>Discussion&amp;nbsp;&amp;nbsp;Adrenocortical carcinoma is a rare malignancy presenting frequently in advanced stage with poor prognosis. Chemotherapy is
 often only moderately effective, while complete surgical resection is potentially curative. In this patient, excellent short-term
 outcome was achieved through radical surgical resection. We continue to monitor her closely for evidence of recurrence.
 
 
 
 
	Content Type Journal ArticleCategory Endocrine TumorsPages 1-1DOI 10.1245/s10434-011-2203-4Authors
		Ryan Z. Swan, Division of Hepatobiliary Surgery, Department of General Surgery, Carolinas Medical Center, Charlotte, NC, USAErin M. Hanna, Division of Hepatobiliary Surgery, Department of General Surgery, Carolinas Medical Center, Charlotte, NC, USADavid Sindram, Division of Hepatobiliary Sur...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5647027</comments>
            <pubDate>Thu, 26 Jan 2012 06:57:08 +0100</pubDate>
            <guid isPermaLink="false">5647027</guid>        </item>
        <item>
            <title>Merkel Cell Carcinoma of Unknown Primary Origin</title>
            <link>http://www.medworm.com/index.php?rid=5638052&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F72850g71v0848068%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Nodal MCCUP is a rare disease affecting primarily elderly white men. Recurrence is observed in approximately one-third of
 patients, with a 104&amp;nbsp;month median overall survival after a multimodal treatment approach consisting of surgery along with
 adjuvant chemotherapy and radiotherapy in the majority of patients.
 
 
 
 
	Content Type Journal ArticleCategory MelanomasPages 1-7DOI 10.1245/s10434-011-2213-2Authors
		Jeremiah L. Deneve, Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USAJane L. Messina, Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USASuroosh S. Marzban, Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USARicardo J. Gonzalez, Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, ...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5638052</comments>
            <pubDate>Tue, 24 Jan 2012 07:52:34 +0100</pubDate>
            <guid isPermaLink="false">5638052</guid>        </item>
        <item>
            <title>The Determining Risk Factors for Treatment Outcomes in Patients with Squamous Cell Carcinoma of the Hard Palate</title>
            <link>http://www.medworm.com/index.php?rid=5638055&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm5p12577t43p1527%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Soft palate invasion and positive/close margins were the determining risk factors for disease-free and overall survival in
 patients with squamous cell carcinoma of the hard palate. Elective neck dissection is suggested for advanced primary tumors
 (T3 or T4) or tumors with soft palate invasion.
 
 
 
 
	Content Type Journal ArticleCategory Head and Neck OncologyPages 1-8DOI 10.1245/s10434-011-2214-1Authors
		Fan-Yu Meng, Department of Otolaryngology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, TaiwanJeng-Yuh Ko, Department of Otolaryngology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, TaiwanPei-Jen Lou, Department of Otolaryngology, National Taiwan University Hosp...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5638055</comments>
            <pubDate>Tue, 24 Jan 2012 07:52:33 +0100</pubDate>
            <guid isPermaLink="false">5638055</guid>        </item>
        <item>
            <title>Diagnostic Accuracy of MRI for Assessment of T Category, Lymph Node Metastases, and Circumferential Resection Margin Involvement in Patients with Rectal Cancer: A Systematic Review and Meta-analysis</title>
            <link>http://www.medworm.com/index.php?rid=5638054&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd44533016413w476%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;MRI has good accuracy for both CRM and T category and should be considered for preoperative rectal cancer staging. In contrast,
 lymph node assessment is poor on MRI.
 
 
 
 
	Content Type Journal ArticleCategory Colorectal CancerPages 1-12DOI 10.1245/s10434-011-2210-5Authors
		Eisar Al-Sukhni, Department of Surgery, Mount Sinai Hospital, Toronto, ON, CanadaLaurent Milot, University of Toronto, Toronto, ON, CanadaMark Fruitman, Department of Diagnostic Imaging, St. Joseph’s Health Centre, Toronto, ON, CanadaJoseph Beyene, Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, CanadaJ. Charles Victor, Institute for Clinical Evaluative Sciences, Toronto, ON, CanadaSelina Schmocker, Department of Surgery, Mount Sinai Hospital, Toront...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5638054</comments>
            <pubDate>Tue, 24 Jan 2012 07:52:33 +0100</pubDate>
            <guid isPermaLink="false">5638054</guid>        </item>
        <item>
            <title>Sentinel Lymph Nodes Containing Very Small (</title>
            <link>http://www.medworm.com/index.php?rid=5638053&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6778117k43720n36%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The results of this study indicate that very small (&amp;lt;0.1&amp;nbsp;mm) deposits of melanoma in SLNs may be associated with adverse clinical
 outcomes and that this is due, at least in part, to the underestimation of SLN tumor burden in the initial sections. Our evidence
 does not support clinical decision-making on the assumption that patients with very small melanoma deposits in SLNs have the
 same outcome as those who are SLN-negative.
 
 
 
 
	Content Type Journal ArticleCategory MelanomasPages 1-11DOI 10.1245/s10434-011-2208-zAuthors
		Rajmohan Murali, Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW, AustraliaChitra DeSilva, Melanoma Institute Australia, Sydney, NSW, AustraliaStanley W. McCarthy, Tissue Pathology and Diagnostic O...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5638053</comments>
            <pubDate>Tue, 24 Jan 2012 07:52:33 +0100</pubDate>
            <guid isPermaLink="false">5638053</guid>        </item>
        <item>
            <title>A Novel Genetically Modified Oncolytic Vaccinia Virus in Experimental Models is Effective Against a Wide Range of Human Cancers</title>
            <link>http://www.medworm.com/index.php?rid=5619651&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk05732055w4n2101%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;GLV-1h151 is effective as an oncolytic agent against a wide range of cancers in cell culture and is effective against pancreatic
 human xenografts displaying a good biosafety profile and ability to be detected via optical imaging. GLV-1h151 thus adds another
 potential medium for the killing of cancer and detection of virus in infected tissue.
 
 
 
 
	Content Type Journal ArticleCategory Translational Research and BiomarkersPages 1-10DOI 10.1245/s10434-011-2198-xAuthors
		Dana Haddad, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USANanhai Chen, Genelux Corporation, San Diego Science Center, San Diego, CA, USAQian Zhang, Genelux Corporation, San Diego Science Center, San Diego, CA, USAChun-Hao Chen, Department of Surgery, Memorial Sloa...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5619651</comments>
            <pubDate>Thu, 19 Jan 2012 07:00:36 +0100</pubDate>
            <guid isPermaLink="false">5619651</guid>        </item>
        <item>
            <title>Survivin-mediated Therapeutic Efficacy of Gemcitabine through Glucose-regulated Protein 78 in Hepatocellular Carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5619652&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3h71m03671x12m47%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;We conclude that survivin knockdown may contribute to a therapeutic effect of gemcitabine through GRP78 on HCC cells.
 
 
 
	Content Type Journal ArticleCategory Translational Research and BiomarkersPages 1-9DOI 10.1245/s10434-011-2188-zAuthors
		Chin-Sheng Hung, Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, TaiwanShen-Fu Lin, Graduate Institute of Biomedical Materials and Engineering, Taipei Medical University, Taipei, TaiwanHui-Hsiung Liu, Department of Public Health, School of Public Health, Taipei Medical University, Taipei, TaiwanLi-Jen Kuo, Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, TaiwanLi-Tzu Li, Imaging Core Facilities, Institute of Cellular and Organism...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5619652</comments>
            <pubDate>Thu, 19 Jan 2012 07:00:35 +0100</pubDate>
            <guid isPermaLink="false">5619652</guid>        </item>
        <item>
            <title>Defined Clinical Classifications Are Associated with Outcome of Patients with Anatomically Resectable Pancreatic Adenocarcinoma Treated with Neoadjuvant Therapy</title>
            <link>http://www.medworm.com/index.php?rid=5619653&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2342xp55q2133547%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;This system describes discrete clinical subgroups of patients with pancreatic cancer who have similar, potentially resectable
 tumor anatomy but heterogeneous physiology and cancer biology. It may be used with neoadjuvant therapy to predict outcomes,
 individualize treatment algorithms, and optimize survival.
 
 
 
 
	Content Type Journal ArticleCategory Pancreatic TumorsPages 1-9DOI 10.1245/s10434-011-2211-4Authors
		Ching-Wei D. Tzeng, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAJason B. Fleming, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAJeffrey E. Lee, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAL...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5619653</comments>
            <pubDate>Thu, 19 Jan 2012 07:00:34 +0100</pubDate>
            <guid isPermaLink="false">5619653</guid>        </item>
        <item>
            <title>NDRG2 Is Involved in the Oncogenic Properties of Renal Cell Carcinoma and Its Loss Is a Novel Independent Poor Prognostic Factor After Nephrectomy</title>
            <link>http://www.medworm.com/index.php?rid=5608139&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp1315358lu230q23%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;These results indicate that a lack of NDRG2 is associated with oncogenic properties through the loss of its role as a tumor suppressor, and that NDRG2 is an independent
 poor prognostic factor predicting survival in clear cell RCC, suggesting that it can serve as a novel prognostic biomarker.
 
 
 
 
	Content Type Journal ArticleCategory Translational Research and BiomarkersPages 1-10DOI 10.1245/s10434-011-2204-3Authors
		Zhe Long Liang, Department of Pathology, Cancer Research Institute, and Infection Signaling Network Research Center, Chungnam National University School of Medicine, Daejeon, Republic of KoreaKyeongah Kang, Department of Biological Science and the Research Center for Women’s Disease, Sookmyung Women’s University, Seoul, Republic of KoreaSukjoon ...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5608139</comments>
            <pubDate>Sat, 14 Jan 2012 06:55:15 +0100</pubDate>
            <guid isPermaLink="false">5608139</guid>        </item>
        <item>
            <title>Evaluation of the Seventh Edition of American Joint Committee on Cancer TNM Staging System for Gastric Cancer: Results from a Chinese Monoinstitutional Study</title>
            <link>http://www.medworm.com/index.php?rid=5596910&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F492312010520r016%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;It is reasonable to subclassify the 6th edition pT2 category and pN1 category into the 7th edition pT2/pT3 category and pN1/pN2
 category, respectively. However, for better prognostic stratification, it might be more suitable for pN3a and pN3b categories
 to be considered individual determinants of the 7th edition TNM staging system.
 
 
 
 
	Content Type Journal ArticleCategory Gastrointestinal OncologyPages 1-10DOI 10.1245/s10434-011-2206-1Authors
		Zhe Sun, Department of Surgical Oncology, First Affiliated Hospital of China Medical University, Shenyang, ChinaZhen-ning Wang, Department of Surgical Oncology, First Affiliated Hospital of China Medical University, Shenyang, ChinaZhi Zhu, Department of Surgical Oncology, First Affiliated Hospital of China Medical Unive...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5596910</comments>
            <pubDate>Fri, 13 Jan 2012 16:56:41 +0100</pubDate>
            <guid isPermaLink="false">5596910</guid>        </item>
        <item>
            <title>Clinical Implication of Elastography as a Prognostic Factor of Papillary Thyroid Microcarcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5596911&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fkq7273711748n554%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;A hard malignancy on the Rago score of elastography was an independent factor for predicting pathologic extrathyroidal extension
 on pathology.
 
 
 
 
	Content Type Journal ArticleCategory Endocrine TumorsPages 1-9DOI 10.1245/s10434-011-2212-3Authors
		Hee Jung Moon, Department of Radiology, Yonsei University College of Medicine, Seoul, Republic of KoreaEun-Kyung Kim, Department of Radiology, Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul, Republic of KoreaJung Hyun Yoon, Department of Radiology, Severance Hospital, Yonsei University, Seoul, Republic of KoreaJin Young Kwak, Department of Radiology, Yonsei University College of Medicine, Seoul, Republic of Korea
	

	
		Journal Annals of Surgical OncologyOnline ISSN 1534-4681P...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5596911</comments>
            <pubDate>Fri, 13 Jan 2012 16:56:40 +0100</pubDate>
            <guid isPermaLink="false">5596911</guid>        </item>
        <item>
            <title>Adjuvant PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) or Gemcitabine Followed by Chemoradiation in Pancreatic Cancer: A Randomized Phase II Trial</title>
            <link>http://www.medworm.com/index.php?rid=5596912&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F366ux67036291216%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The 4-drug regimen deserves further assessment in resectable pancreatic cancer.
 
 
 
	Content Type Journal ArticleCategory Pancreatic TumorsPages 1-8DOI 10.1245/s10434-011-2205-2Authors
		Michele Reni, Department of Oncology, S. Raffaele Scientific Institute, Milan, ItalyGianpaolo Balzano, Department of Surgery, S. Raffaele Scientific Institute, Milan, ItalyGiuseppe Aprile, Department of Oncology, University Hospital, Udine, ItalyStefano Cereda, Department of Oncology, S. Raffaele Scientific Institute, Milan, ItalyPaolo Passoni, Department of Radiotherapy, S. Raffaele Scientific Institute, Milan, ItalyAlessandro Zerbi, Pancreatic Surgery Section, Humanitas Scientific Institute, Rozzano, ItalyMaria Chiara Tronconi, Medical Oncology and Hematology, Humanitas Scientifi...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5596912</comments>
            <pubDate>Thu, 12 Jan 2012 06:42:49 +0100</pubDate>
            <guid isPermaLink="false">5596912</guid>        </item>
        <item>
            <title>Micrometastases in Sentinel Lymph Nodes: Not Getting Lost in Translation</title>
            <link>http://www.medworm.com/index.php?rid=5596913&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F1j72687482381k84%2F</link>
            <description>Content Type Journal ArticleCategory MelanomasPages 1-2DOI 10.1245/s10434-011-2215-0Authors
		Sandra L. Wong, Department of Surgery, University of Michigan, Ann Arbor, MI, USA
	

	
		Journal Annals of Surgical OncologyOnline ISSN 1534-4681Print ISSN 1068-9265 (Source: Annals of Surgical Oncology)</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5596913</comments>
            <pubDate>Tue, 10 Jan 2012 06:41:22 +0100</pubDate>
            <guid isPermaLink="false">5596913</guid>        </item>
        <item>
            <title>Compartmental Differences of Circulating Tumor Cells in Colorectal Cancer</title>
            <link>http://www.medworm.com/index.php?rid=5596914&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7634936113w61606%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The qualitative and quantitative detection of CTCs is higher in the MVBC compared with the CVBC of patients with CRC.
 
 
 
	Content Type Journal ArticleCategory Colorectal CancerPages 1-8DOI 10.1245/s10434-011-2178-1Authors
		Nuh N. Rahbari, Department of General, Visceral, and Transplant Surgery, University of Heidelberg, Heidelberg, GermanyUlrich Bork, Department of General, Visceral, and Transplant Surgery, University of Heidelberg, Heidelberg, GermanyAlexandra Kircher, Department of General, Visceral, and Transplant Surgery, University of Heidelberg, Heidelberg, GermanyThomas Nimitz, Department of General, Visceral, and Transplant Surgery, University of Heidelberg, Heidelberg, GermanySebastian Schölch, Department of General, Visceral, and Transplant Surgery, Un...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5596914</comments>
            <pubDate>Mon, 09 Jan 2012 19:40:30 +0100</pubDate>
            <guid isPermaLink="false">5596914</guid>        </item>
        <item>
            <title>Accuracy of Predicting Axillary Lymph Node Positivity by Physical Examination, Mammography, Ultrasonography, and Magnetic Resonance Imaging</title>
            <link>http://www.medworm.com/index.php?rid=5580996&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe972677746960666%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Physical examination and multimodal imaging in combination are useful for preoperative axillary staging and treatment planning.
 However, they remain inadequate definitive predictors of axillary lymph node involvement.
 
 
 
 
	Content Type Journal ArticleCategory Breast OncologyPages 1-6DOI 10.1245/s10434-011-2200-7Authors
		Stephanie A. Valente, Division of Breast and Soft Tissue Surgery, Department of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA, USAGary M. Levine, Division of Breast Services, Department of Radiology, Hoag Memorial Hospital Presbyterian, Newport Beach, CA, USAMelvin J. Silverstein, Division of Breast and Soft Tissue Surgery, Department of Surgery, Keck School of Medicine, University of Southern California, L...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5580996</comments>
            <pubDate>Fri, 06 Jan 2012 16:43:45 +0100</pubDate>
            <guid isPermaLink="false">5580996</guid>        </item>
        <item>
            <title>Risk of Subsequent Primary Thyroid Cancer after Another Malignancy: Latency Trends in a Population-based Study</title>
            <link>http://www.medworm.com/index.php?rid=5580997&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm0h0lp7521768812%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Many common cancers are associated with increased risk of SPTC beyond 12&amp;nbsp;months of initial diagnosis. Although this can be
 explained partly by continued surveillance bias, radiation effects, and known rare familial associations for some tumors,
 these factors alone are unlikely to explain the persistent, significant two-way association with renal and breast cancers.
 Additional research is needed to further define the biological and environmental mechanisms underlying these associations.
 
 
 
 
	Content Type Journal ArticleCategory Endocrine TumorsPages 1-10DOI 10.1245/s10434-011-2193-2Authors
		Geeta Lal, Department of Surgery, University of Iowa Hospitals and Clinics, Iowa City, IA, USAMegan Groff, Department of Surgery, University of Iowa Hospitals and Clin...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5580997</comments>
            <pubDate>Fri, 06 Jan 2012 16:43:43 +0100</pubDate>
            <guid isPermaLink="false">5580997</guid>        </item>
        <item>
            <title>Combination of Haptoglobin and Osteopontin Could Predict Colorectal Cancer Hepatic Metastasis</title>
            <link>http://www.medworm.com/index.php?rid=5571937&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu3407104ll6t45m2%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Our results suggest that combined HP and OPN expression levels are significantly related to liver metastasis and prognosis,
 and, if this is validated, they could be used as accurate predictors of liver metastasis in colorectal cancer.
 
 
 
 
	Content Type Journal ArticleCategory Translational Research and BiomarkersPages 1-9DOI 10.1245/s10434-011-2177-2Authors
		Lichao Sun, State Key Laboratory of Molecular Oncology, Cancer Institute (Hospital), Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, People’s Republic of ChinaJian Pan, Department of Hematology and Oncology, Children’s Hospital of Soochow University, Suzhou, ChinaLiang Peng, Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing, People’s Republic ...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5571937</comments>
            <pubDate>Wed, 04 Jan 2012 16:51:04 +0100</pubDate>
            <guid isPermaLink="false">5571937</guid>        </item>
        <item>
            <title>Training a New Generation of Breast Surgeons: Are We Succeeding?</title>
            <link>http://www.medworm.com/index.php?rid=5571936&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4t5x62r61k016786%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;SSO breast oncology fellowships appear to be training confident, well-prepared graduates with good job outlooks, and many
 are achieving leadership positions. Deficiencies in sonography training, some advanced surgical techniques, and administrative
 experiences should be addressed by program directors as graduates do perceive the need for such training.
 
 
 
 
	Content Type Journal ArticleCategory Breast OncologyPages 1-6DOI 10.1245/s10434-011-2164-7Authors
		Lisa M. Sclafani, Breast Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USAAaron Bleznak, Section of Surgical Oncology, Lehigh Valley Health Network, John &amp; Dorothy Morgan Cancer Center, Allentown, PA, USATricia Kelly, Breast Care Specialists, Allentown, PA, USAMahmoud B....</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5571936</comments>
            <pubDate>Wed, 04 Jan 2012 16:51:04 +0100</pubDate>
            <guid isPermaLink="false">5571936</guid>        </item>
        <item>
            <title>UHRF1 Promotes Cell Growth and Metastasis Through Repression of p16ink4a in Colorectal Cancer</title>
            <link>http://www.medworm.com/index.php?rid=5571939&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft0881682903765x1%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;UHRF1 expression is upregulated in CRC and is associated with the progression of CRC. Moreover, RNAi of UHRF1 decreases proliferation and migration but enhances apoptosis of CRC cells, with increased p16ink4a expression. UHRF1 promotes CRC growth and metastasis, likely by repressing p16ink4a, and thus it may be used as a biomarker or even a therapeutic target for CRC.
 
 
 
 
	Content Type Journal ArticleCategory Translational Research and BiomarkersPages 1-10DOI 10.1245/s10434-011-2194-1Authors
		Feng Wang, Department of Surgery, Sixth People’s Hospital Affiliated to Shanghai Jiaotong University, Shanghai, ChinaYong-Zhi Yang, Department of Surgery, Sixth People’s Hospital Affiliated to Shanghai Jiaotong University, Shanghai, ChinaChen-Zhang Shi, Department of Su...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5571939</comments>
            <pubDate>Wed, 04 Jan 2012 16:51:03 +0100</pubDate>
            <guid isPermaLink="false">5571939</guid>        </item>
        <item>
            <title>Evolution of Long-Term Outcome of Liver Resection for Colorectal Metastases: Analysis of Actual 5-Year Survival Rates over Two Decades</title>
            <link>http://www.medworm.com/index.php?rid=5571938&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fbt3m64j425824717%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Long-term outcome of LR for CRLM improved over 20&amp;nbsp;years, even in patients with negative prognostic factors, linked to hepatic
 recurrences reduction and increased survival after recurrence.
 
 
 
 
	Content Type Journal ArticleCategory Hepatobiliary TumorsPages 1-10DOI 10.1245/s10434-011-2186-1Authors
		Luca Viganò, Department of HPB and Digestive Surgery, Ospedale Mauriziano Umberto I, Turin, ItalyNadia Russolillo, Department of HPB and Digestive Surgery, Ospedale Mauriziano Umberto I, Turin, ItalyAlessandro Ferrero, Department of HPB and Digestive Surgery, Ospedale Mauriziano Umberto I, Turin, ItalySerena Langella, Department of HPB and Digestive Surgery, Ospedale Mauriziano Umberto I, Turin, ItalyElisa Sperti, Department of Oncology, Ospedale Mauriziano Umbe...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5571938</comments>
            <pubDate>Wed, 04 Jan 2012 16:51:03 +0100</pubDate>
            <guid isPermaLink="false">5571938</guid>        </item>
        <item>
            <title>Long-Term Outcome of Isolated Limb Perfusion in Advanced Soft Tissue Sarcoma of the Extremity</title>
            <link>http://www.medworm.com/index.php?rid=5571941&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2763150306777067%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;TM-ILP of advanced soft tissue sarcoma of the extremities makes limb-sparing surgery possible in a high proportion of patients.
 
 
 
	Content Type Journal ArticleCategory Bone and Soft Tissue SarcomasPages 1-8DOI 10.1245/s10434-011-2196-zAuthors
		R. Olofsson, Department of Surgery, Sahlgrenska University Hospital, Göteborg, SwedenP. Bergh, Department of Orthopaedics, Sahlgrenska University Hospital, Göteborg, SwedenÖ. Berlin, Department of Orthopaedics, Sahlgrenska University Hospital, Göteborg, SwedenK. Engström, Department of Oncology, Sahlgrenska University Hospital, Göteborg, SwedenB. Gunterberg, Department of Orthopaedics, Sahlgrenska University Hospital, Göteborg, SwedenM. Hansson, Department of Pathology, Sahlgrenska University Hospital, Göteborg, Sw...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5571941</comments>
            <pubDate>Wed, 04 Jan 2012 16:51:02 +0100</pubDate>
            <guid isPermaLink="false">5571941</guid>        </item>
        <item>
            <title>Prognostic Factors for Locoregional Recurrences in Colon Cancer</title>
            <link>http://www.medworm.com/index.php?rid=5571940&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fap102h4631m86760%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Although the locoregional recurrence rate in this study was relatively low, it remains a considerable problem. Identifying
 individual patients who might benefit from adjuvant chemotherapy may reduce the locoregional recurrence rate.
 
 
 
 
	Content Type Journal ArticleCategory Colorectal CancerPages 1-9DOI 10.1245/s10434-011-2183-4Authors
		M. A. G. Elferink, Comprehensive Cancer Centre the Netherlands, Utrecht, The NetherlandsO. Visser, Comprehensive Cancer Centre the Netherlands, Utrecht, The NetherlandsT. Wiggers, Department of Surgery, University Medical Centre Groningen, University of Groningen, Groningen, The NetherlandsR. Otter, Comprehensive Cancer Centre the Netherlands, Utrecht, The NetherlandsR. A. E. M. Tollenaar, Department of Surgery, Leiden Universit...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5571940</comments>
            <pubDate>Wed, 04 Jan 2012 16:51:02 +0100</pubDate>
            <guid isPermaLink="false">5571940</guid>        </item>
        <item>
            <title>Repeat Hepatectomy for Metastatic Colorectal Cancer Is Safe but Marginally Effective</title>
            <link>http://www.medworm.com/index.php?rid=5559416&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp6x0682137g238q6%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Repeat hepatectomy for mCRC is feasible in highly selected patients, with acceptable perioperative morbidity and mortality.
 Although repeat hepatectomy should be considered, recurrence rates are high. Although the initial hepatectomy for mCRC is
 potentially curative, recurrence of metastatic disease in the liver is unlikely to be cured.
 
 
 
 
	Content Type Journal ArticleCategory Colorectal CancerPages 1-6DOI 10.1245/s10434-011-2179-0Authors
		Natalie B. Jones, Department of Surgery, The Ohio State University, Columbus, OH, USAMegan E. McNally, Department of Surgery, The Ohio State University, Columbus, OH, USALavina Malhotra, Department of Surgery, The Ohio State University, Columbus, OH, USASherif Abdel-Misih, Department of Surgery, The Ohio State University, C...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5559416</comments>
            <pubDate>Fri, 30 Dec 2011 06:50:05 +0100</pubDate>
            <guid isPermaLink="false">5559416</guid>        </item>
        <item>
            <title>Prognostic Value of Number of Removed Lymph Nodes, Number of Involved Lymph Nodes, and Lymph Node Ratio in 7502 Breast Cancer Patients Enrolled onto Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)</title>
            <link>http://www.medworm.com/index.php?rid=5559417&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fxw0173644773m7j3%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;For breast cancer patients stringently medicated in the framework of prospective adjuvant clinical trials and requiring a
 mandatory minimum of removed nodes, NRN does not influence prognosis, and LNR is not superior to NIN as prognostic factor.
 In patients with one to three positive lymph nodes and mastectomy, LNR could play a role as an additional prognostic factor.
 
 
 
 
	Content Type Journal ArticleCategory Breast OncologyPages 1-10DOI 10.1245/s10434-011-2189-yAuthors
		Christoph Tausch, Department of Surgery, Brust-Zentrum, Seefeldstrasse 214, 8008 Zürich, SwitzerlandSusanne Taucher, Department of Gynecology and Obstetrics, Vienna University Medical School, Innsbruck, AustriaPeter Dubsky, Department of General Surgery, Vienna University Medical School, Vienn...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5559417</comments>
            <pubDate>Fri, 30 Dec 2011 06:50:04 +0100</pubDate>
            <guid isPermaLink="false">5559417</guid>        </item>
        <item>
            <title>High Intersystem Variability for the Prediction of Additional Axillary Non-Sentinel Lymph Node Involvement in Individual Patients with Sentinel Node-Positive Breast Cancer</title>
            <link>http://www.medworm.com/index.php?rid=5559418&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn120rnm738028515%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;This study shows that there is an unacceptably high variability in individual predictions when the predictive systems that
 are currently available are used to predict non-SLN metastasis in patients with SLN-positive breast cancer.
 
 
 
 
	Content Type Journal ArticleCategory Breast OncologyPages 1-9DOI 10.1245/s10434-011-2169-2Authors
		Ingrid van den Hoven, Department of General Surgery, Máxima Medical Centre, Veldhoven, The NetherlandsGerrit P. Kuijt, Department of General Surgery, Máxima Medical Centre, Veldhoven, The NetherlandsAdri C. Voogd, Department of Epidemiology, University of Maastricht, Maastricht, The NetherlandsRudi M. H. Roumen, Department of General Surgery, Máxima Medical Centre, Veldhoven, The Netherlands
	

	
		Journal Annals of Surgical Onco...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5559418</comments>
            <pubDate>Fri, 30 Dec 2011 06:50:03 +0100</pubDate>
            <guid isPermaLink="false">5559418</guid>        </item>
        <item>
            <title>Development and Evaluation of a Checklist to Support Decision Making in Cancer Multidisciplinary Team Meetings: MDT-QuIC</title>
            <link>http://www.medworm.com/index.php?rid=5559421&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F5h076677xj276787%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;We have developed and validated an evidence-based tool to support the quality of MDT decision making. MDT members were positive
 about the checklist and felt it may help to structure discussion, improve inclusivity, and patient centeredness. Further research
 is needed to assess its effect on patient care and outcomes.
 
 
 
 
	Content Type Journal ArticleCategory Healthcare Policy and OutcomesPages 1-7DOI 10.1245/s10434-011-2187-0Authors
		B. W. Lamb, Department of Surgery and Cancer, Imperial College London, London, UKN. Sevdalis, Department of Surgery and Cancer, Imperial College London, London, UKC. Vincent, Department of Surgery and Cancer, Imperial College London, London, UKJ. S. A. Green, Department of Urology, Whipps Cross University Hospital, London, UK
	

	
...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5559421</comments>
            <pubDate>Fri, 30 Dec 2011 06:50:02 +0100</pubDate>
            <guid isPermaLink="false">5559421</guid>        </item>
        <item>
            <title>The Combination of Surgery and Imatinib in GIST: A Reality for Localized Tumors at High Risk, an Open Issue for Metastatic Ones</title>
            <link>http://www.medworm.com/index.php?rid=5559420&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm4372250m6r53333%2F</link>
            <description>Content Type Journal ArticleCategory Bone and Soft Tissue SarcomasPages 1-5DOI 10.1245/s10434-011-2191-4Authors
		Alessandro Gronchi, Department of Surgery, Sarcoma Service, Fondazione IRCCS Istituto Nazionale Tumori, Milan, ItalyChandrajit P. Raut, Department of Surgery, Brigham and Women’s Hospital, Boston, MA, USA
	

	
		Journal Annals of Surgical OncologyOnline ISSN 1534-4681Print ISSN 1068-9265 (Source: Annals of Surgical Oncology)</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5559420</comments>
            <pubDate>Fri, 30 Dec 2011 06:50:02 +0100</pubDate>
            <guid isPermaLink="false">5559420</guid>        </item>
        <item>
            <title>A Comparison of Outcomes for Younger and Older Adult Patients Undergoing Surgery for Primary Hyperparathyroidism</title>
            <link>http://www.medworm.com/index.php?rid=5559419&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw357785434j20671%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Younger patients with PHPT present with significantly higher serum calcium levels than older patients. However, younger patients
 are less likely to localize abnormal parathyroid glands on sestamibi or ultrasound. Though younger patients appear to have
 a higher incidence of hyperplasia compared with older patients, single gland disease is still the overall most frequent cause.
 Our data suggest that MIP should be more frequently considered in younger patients because of the high incidence of single
 gland disease.
 
 
 
 
	Content Type Journal ArticleCategory Endocrine TumorsPages 1-5DOI 10.1245/s10434-011-2185-2Authors
		Emad Kandil, Department of Surgery, Tulane University School of Medicine, New Orleans, LouisianaDewan Safwan Majid, Department of Surgery, Tulane ...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5559419</comments>
            <pubDate>Fri, 30 Dec 2011 06:50:02 +0100</pubDate>
            <guid isPermaLink="false">5559419</guid>        </item>
        <item>
            <title>Feasibility of Sentinel Node Biopsy in Head and Neck Melanoma Using a Hybrid Radioactive and Fluorescent Tracer</title>
            <link>http://www.medworm.com/index.php?rid=5559423&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu5m0750t7747j788%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;ICG–99mTc-nanocolloid allows for preoperative sentinel node visualization and concomitant intraoperative radio- and fluorescence
 guidance to the same sentinel nodes in head and neck melanoma patients.
 
 
 
 
	Content Type Journal ArticleCategory Head and Neck OncologyPages 1-7DOI 10.1245/s10434-011-2180-7Authors
		Oscar R. Brouwer, Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The NetherlandsW. Martin C. Klop, Department of Head &amp; Neck Surgery and Oncology, The Netherlands Cancer Institute, Amsterdam, The NetherlandsTessa Buckle, Department of Radiology, Leiden University Medical Center, Leiden, The NetherlandsLenka Vermeeren, Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The NetherlandsMichiel W. M. v...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5559423</comments>
            <pubDate>Fri, 30 Dec 2011 06:50:01 +0100</pubDate>
            <guid isPermaLink="false">5559423</guid>        </item>
        <item>
            <title>VEGF-A/VEGFR-2 Signaling Plays an Important Role for the Motility of Pancreas Cancer Cells</title>
            <link>http://www.medworm.com/index.php?rid=5559422&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F44810k8w236g73l3%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;VEGF-A/VEGFR-2 signaling plays an important role in inducing invasion and migration of pancreatic cancer cells.
 
 
 
	Content Type Journal ArticleCategory Translational Research and BiomarkersPages 1-11DOI 10.1245/s10434-011-2181-6Authors
		Yosuke Doi, Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, JapanMasakazu Yashiro, Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, JapanNobuya Yamada, Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, JapanRyosuke Amano, Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, JapanSatoru Noda, Department of Surgical Oncology, Osaka City University Graduate School of Medi...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5559422</comments>
            <pubDate>Fri, 30 Dec 2011 06:50:01 +0100</pubDate>
            <guid isPermaLink="false">5559422</guid>        </item>
        <item>
            <title>Prognostication of Soft Tissue Sarcomas Based on Chromosome 17q Gene and Protein Status: Evaluation of TOP2A, HER-2/neu, and Survivin</title>
            <link>http://www.medworm.com/index.php?rid=5552009&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm2062814n688h1h6%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;These findings might become valuable in the management of patients with STS and possibly in the prospective evaluation of
 responses to new target-driven therapies.
 
 
 
 
	Content Type Journal ArticleCategory Bone and Soft Tissue SarcomasPages 1-10DOI 10.1245/s10434-011-2184-3Authors
		Isabela Werneck da Cunha, Hospital do Câncer A. C. Camargo, Fundação Antonio Prudente, São Paulo, BrazilLouise De Brot, Hospital do Câncer A. C. Camargo, Fundação Antonio Prudente, São Paulo, BrazilKátia Cândido Carvalho, Hospital do Câncer A. C. Camargo, Fundação Antonio Prudente, São Paulo, BrazilRafael Malagoli Rocha, Hospital do Câncer A. C. Camargo, Fundação Antonio Prudente, São Paulo, BrazilJosé Humberto Fregnani, Hospital do Câncer A. C. Camargo, Fundaçã...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5552009</comments>
            <pubDate>Wed, 28 Dec 2011 06:52:29 +0100</pubDate>
            <guid isPermaLink="false">5552009</guid>        </item>
        <item>
            <title>Putatively Functional PLCE1 Variants and Susceptibility to Esophageal Squamous Cell Carcinoma (ESCC): A Case–Control Study in Eastern Chinese Populations</title>
            <link>http://www.medworm.com/index.php?rid=5552011&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fvk7rt2x703644243%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;
 PLCE1 SNP rs2274223 A&amp;gt;G change may reduce gene expression, and the variant G genotypes might contribute to risk of ESCC.
 
 
 
 
	Content Type Journal ArticleCategory Translational Research and BiomarkersPages 1-8DOI 10.1245/s10434-011-2160-yAuthors
		Haichuan Hu, Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, ChinaJingmin Yang, State Key Laboratory of Genetic Engineering and MOE Key Laboratory of Contemporary Anthropology, School of Life Sciences and Institutes of Biomedical Sciences, Fudan University, Shanghai, ChinaYihua Sun, Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, ChinaYajun Yang, State Key Laboratory of Genetic Engineering and MOE Key Laboratory of Contemporary Anthropology, Scho...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5552011</comments>
            <pubDate>Wed, 28 Dec 2011 06:52:28 +0100</pubDate>
            <guid isPermaLink="false">5552011</guid>        </item>
        <item>
            <title>Treatment for T1-2 Oral Squamous Cell Carcinoma with or Without Perineural Invasion: Neck Dissection and Postoperative Adjuvant Therapy</title>
            <link>http://www.medworm.com/index.php?rid=5552010&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F5x53140885425r6g%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Elective neck dissection is indicated for cN0 patients with PNI-positive tumors for the efficacy of improving disease-specific
 survival as well as neck control. However, low-risk PNI-positive patients who undergo neck dissection do not need postoperative
 adjuvant therapy, because the residual risk from PNI is minimal.
 
 
 
 
	Content Type Journal ArticleCategory Head and Neck OncologyPages 1-8DOI 10.1245/s10434-011-2182-5Authors
		Shyh-Kuan Tai, Department of Otolaryngology, National Yang-Ming University, Taipei, TaiwanWing-Yin Li, Department of Pathology, Taipei Veterans General Hospital, Taipei, TaiwanMuh-Hwa Yang, Department of Otolaryngology, Taipei Veterans General Hospital, Taipei, TaiwanShyue-Yih Chang, Department of Otolaryngology, National Yang-Ming Unive...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5552010</comments>
            <pubDate>Wed, 28 Dec 2011 06:52:28 +0100</pubDate>
            <guid isPermaLink="false">5552010</guid>        </item>
        <item>
            <title>Cytokeratin 7 is a Predictive Marker for Survival in Patients with Esophageal Squamous Cell Carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5552012&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F406kr1k3145756u8%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Immunohistochemical analysis of CK7 will help to identify high-risk patients.
 
 
 
	Content Type Journal ArticleCategory Thoracic OncologyPages 1-9DOI 10.1245/s10434-011-2175-4Authors
		Naohide Oue, Department of Molecular Pathology, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, JapanTsuyoshi Noguchi, Center for Community Medicine, Division of Surgery, Oita University Faculty of Medicine, Yufu, JapanKatsuhiro Anami, Department of Molecular Pathology, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, JapanSeigo Kitano, Department of Surgery I, Oita University Faculty of Medicine, Yufu, JapanNaoya Sakamoto, Department of Molecular Pathology, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, JapanKaz...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5552012</comments>
            <pubDate>Wed, 28 Dec 2011 06:52:27 +0100</pubDate>
            <guid isPermaLink="false">5552012</guid>        </item>
        <item>
            <title>Factors Affecting Lymph Node Yield in Patients Undergoing Axillary Node Dissection for Primary Breast Cancer: A Single-Institution Review</title>
            <link>http://www.medworm.com/index.php?rid=5552014&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb35h0r8412873267%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Age, type of breast surgery, body mass index, and clinical stage have no effect on yield of lymph nodes at axillary lymph
 node dissection. Neoadjuvant chemotherapy, however, is associated with a far fewer nodes at axillary dissection, and alteration
 of the guidelines should be considered for this population of patients.
 
 
 
 
	Content Type Journal ArticleCategory Breast OncologyPages 1-7DOI 10.1245/s10434-011-2199-9Authors
		Marie Catherine Lee, Surgical Oncology, Comprehensive Breast Program, Moffitt Cancer Center, Tampa, FL, USARobert Plews, Department of General Surgery, The Ohio State University Medical Center, Columbus, OH, USABhupendra Rawal, Biostatistics Core, Moffitt Cancer Center, Tampa, FL, USAJohn V. Kiluk, Surgical Oncology, Comprehensive Breast Prog...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5552014</comments>
            <pubDate>Wed, 28 Dec 2011 06:52:26 +0100</pubDate>
            <guid isPermaLink="false">5552014</guid>        </item>
        <item>
            <title>Does the Final Intraoperative PTH Level Really Have to Fall into the Normal Range to Signify Cure?</title>
            <link>http://www.medworm.com/index.php?rid=5552013&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk3832p7m77258230%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Allowing the IOPTH to fall by 50% by 15&amp;nbsp;min, regardless of whether the IOPTH falls into the normal range, results in a high
 success rate when performed by experienced surgeons. This helps reduce intraoperative time used waiting for additional parathyroid
 hormone levels and the risks associated with unnecessary bilateral neck exploration.
 
 
 
 
	Content Type Journal ArticleCategory Endocrine TumorsPages 1-6DOI 10.1245/s10434-011-2192-3Authors
		Alexandra E. Reiher, Division of Endocrinology, Department of Internal Medicine, University of Wisconsin, Madison, WI, USASarah Schaefer, Department of Surgery, Section of Endocrine Surgery, University of Wisconsin, Madison, WI, USAHerbert Chen, Department of Surgery, Section of Endocrine Surgery, University of Wiscons...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5552013</comments>
            <pubDate>Wed, 28 Dec 2011 06:52:26 +0100</pubDate>
            <guid isPermaLink="false">5552013</guid>        </item>
        <item>
            <title>Predictors for Microinvasion of Small Hepatocellular Carcinoma ≤2 cm</title>
            <link>http://www.medworm.com/index.php?rid=5552015&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft3274167tj43u137%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Even in cases of HCC ≤2&amp;nbsp;cm, patients who are suspected of having invasive gross type tumors in preoperative imaging diagnosis
 or who have a high DCP level (&amp;gt;100&amp;nbsp;mAU/ml) are at risk for MI. Therefore, in such patients, hepatic resection with a wide
 tumor margin should be recommended.
 
 
 
 
	Content Type Journal ArticleCategory Hepatobiliary TumorsPages 1-8DOI 10.1245/s10434-011-2195-0Authors
		Yo-ichi Yamashita, Department of Surgery, Hiroshima Red Cross Hospital and Atomic Bomb Survivors Hospital, Hiroshima, JapanEiji Tsuijita, Department of Surgery, Hiroshima Red Cross Hospital and Atomic Bomb Survivors Hospital, Hiroshima, JapanKazuki Takeishi, Department of Surgery, Hiroshima Red Cross Hospital and Atomic Bomb Survivors Hospital, Hiroshima, Japa...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5552015</comments>
            <pubDate>Wed, 28 Dec 2011 06:52:25 +0100</pubDate>
            <guid isPermaLink="false">5552015</guid>        </item>
        <item>
            <title>Phase II Trial of Neoadjuvant/adjuvant Imatinib Mesylate for Advanced Primary and Metastatic/recurrent Operable Gastrointestinal Stromal Tumors: Long-term Follow-up Results of Radiation Therapy Oncology Group 0132</title>
            <link>http://www.medworm.com/index.php?rid=5552016&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh3p229802170lu74%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;This long-term analysis suggests a high percentage of patients experienced disease progression after discontinuation of 2-year
 maintenance imatinib therapy after surgery. Consideration should be given to studying longer treatment durations in intermediate-
 to high-risk GIST patients.
 
 
 
 
	Content Type Journal ArticleCategory Bone and Soft Tissue SarcomasPages 1-7DOI 10.1245/s10434-011-2190-5Authors
		Dian Wang, Medical College of Wisconsin, Milwaukee, WI, USAQiang Zhang, Radiation Therapy Oncology Group Statistical Center, Philadelphia, PA, USACharles D. Blanke, University of British Columbia and British Columbia Cancer Agency, Vancouver, BC, CanadaGeorge D. Demetri, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USAMichael C. Heinrich, Po...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5552016</comments>
            <pubDate>Wed, 28 Dec 2011 06:52:23 +0100</pubDate>
            <guid isPermaLink="false">5552016</guid>        </item>
        <item>
            <title>Preoperative Ultrasound is Not Useful for Identifying Nodal Metastasis in Melanoma Patients Undergoing Sentinel Node Biopsy: Preoperative Ultrasound in Clinically Node-Negative Melanoma</title>
            <link>http://www.medworm.com/index.php?rid=5544125&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe7772815815p405p%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Routine preoperative ultrasound in clinically node-negative melanoma is impractical because of its low sensitivity. Selected
 patients with thick or ulcerated lesions may benefit. Because of variable lymphatic drainage patterns, preoperative ultrasound
 without lymphoscintigraphic localization will provide incomplete evaluation in many cases.
 
 
 
 
	Content Type Journal ArticleCategory MelanomasPages 1-7DOI 10.1245/s10434-011-2172-7Authors
		Christy Y. Chai, Department of Surgery, San Antonio Military Medical Center, San Antonio, TX, USAJonathan S. Zager, Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USAMargaret M. Szabunio, Division of Women’s Radiology, University of Kentucky College of Medicine, Lexington, KY, USASuroosh S. Marzban, Depar...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5544125</comments>
            <pubDate>Thu, 22 Dec 2011 16:37:02 +0100</pubDate>
            <guid isPermaLink="false">5544125</guid>        </item>
        <item>
            <title>Recommendations from an International Consensus Conference on the Current Status and Future of Neoadjuvant Systemic Therapy in Primary Breast Cancer</title>
            <link>http://www.medworm.com/index.php?rid=5544127&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl88k6453022t1528%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The use of neoadjuvant systemic therapy (NST) for the treatment of primary breast cancer has constantly increased, especially
 in trials of new therapeutic regimens. In the 1980&amp;nbsp;s, NST was shown to substantially improve breast-conserving surgery rates
 and was first typically used for patients with inoperable locally advanced or inflammatory breast cancer. Investigators have
 since also used NST as an in vivo test for chemosensitivity by assessing pathologic complete response. Today, by using pathologic
 response and other biomarkers as intermediate end points, results from trials of new regimens and therapies that use NST are
 aimed to precede and anticipate the results from larger adjuvant trials. In 2003, a panel of representatives from various
 breast cancer cl...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5544127</comments>
            <pubDate>Thu, 22 Dec 2011 16:37:01 +0100</pubDate>
            <guid isPermaLink="false">5544127</guid>        </item>
        <item>
            <title>Clinical Impact of Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma</title>
            <link>http://www.medworm.com/index.php?rid=5544126&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F5584470v5t4g0063%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Extrapleural pneumonectomy has a significant and durable impact on function and symptoms as well as on physical and mental
 components of quality of life in patients with malignant pleural mesothelioma.
 
 
 
 
	Content Type Journal ArticleCategory Thoracic OncologyPages 1-8DOI 10.1245/s10434-011-2171-8Authors
		Vincenzo Ambrogi, Department of Thoracic Surgery, Tor Vergata University, Rome, ItalyAlfonso Baldi, Department of Biochemistry, Section of Pathology, Second University of Naples, Naples, ItalyOrazio Schillaci, Department of Biopathology and Diagnostic Imaging, Tor Vergata University, Rome, ItalyTommaso Claudio Mineo, Department of Thoracic Surgery, Tor Vergata University, Rome, Italy
	

	
		Journal Annals of Surgical OncologyOnline ISSN 1534-4681Print ISSN 10...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5544126</comments>
            <pubDate>Thu, 22 Dec 2011 16:37:01 +0100</pubDate>
            <guid isPermaLink="false">5544126</guid>        </item>
        <item>
            <title>Prognostic Significance and Molecular Associations of Tumor Growth Pattern in Colorectal Cancer</title>
            <link>http://www.medworm.com/index.php?rid=5544128&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg44q742t6q753548%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Infiltrative growth pattern was associated with worse prognosis among stage I–III colorectal cancer patients, independent
 of other clinical, pathologic, and molecular characteristics.
 
 
 
 
	Content Type Journal ArticleCategory Gastrointestinal OncologyPages 1-10DOI 10.1245/s10434-011-2174-5Authors
		Teppei Morikawa, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USAAya Kuchiba, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USAZhi Rong Qian, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USAMari Mino-Kenudson, Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, M...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5544128</comments>
            <pubDate>Thu, 22 Dec 2011 06:44:42 +0100</pubDate>
            <guid isPermaLink="false">5544128</guid>        </item>
        <item>
            <title>Robot-Assisted Selective Neck Dissection via Modified Face-lift Approach for Early Oral Tongue Cancer: A Video Demonstration</title>
            <link>http://www.medworm.com/index.php?rid=5544130&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl1335q5v426v5430%2F</link>
            <description>Content Type Journal ArticleCategory Head and Neck OncologyPages 1-2DOI 10.1245/s10434-011-2155-8Authors
		Yoon Woo Koh, Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, Republic of KoreaWoong Youn Chung, Department of Surgery, Yonsei University College of Medicine, Seoul, Republic of KoreaHyun Jun Hong, Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, Republic of KoreaSo-Yoon Lee, Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, Republic of KoreaWon Shik Kim, Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, Republic of KoreaHyoung Shin Lee, Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, Republic of KoreaEun Chang Choi, Departme...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5544130</comments>
            <pubDate>Wed, 21 Dec 2011 20:14:28 +0100</pubDate>
            <guid isPermaLink="false">5544130</guid>        </item>
        <item>
            <title>A Population-Based Comparison of Adenocarcinoma of the Large and Small Intestine: Insights Into a Rare Disease</title>
            <link>http://www.medworm.com/index.php?rid=5544129&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv8146xrw31p700wk%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Adequate nodal assessment is much less common in SBA than LBA; and it appears that SBA, in particular duodenal adenocarcinoma,
 is understaged. Even after corrections to minimize the effect of stage migration and inadequate lymph node evaluation, SBA
 demonstrated distinctly worse CSS than LBA.
 
 
 
 
	Content Type Journal ArticleCategory Healthcare Policy and OutcomesPages 1-7DOI 10.1245/s10434-011-2173-6Authors
		Michael J. Overman, Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USAChung-Yuan Hu, Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USAScott Kopetz, Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Hous...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5544129</comments>
            <pubDate>Wed, 21 Dec 2011 20:14:28 +0100</pubDate>
            <guid isPermaLink="false">5544129</guid>        </item>
        <item>
            <title>Pyrosequencing Assay to Measure LINE-1 Methylation Level in Esophageal Squamous Cell Carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5544132&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0152rgu7gu873801%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Bisulfite conversion and PCR pyrosequencing assay can measure LINE-1 methylation in ESCC, and may be useful in clinical and
 research settings.
 
 
 
 
	Content Type Journal ArticleCategory Translational Research and BiomarkersPages 1-7DOI 10.1245/s10434-011-2176-3Authors
		Shiro Iwagami, Department of Gastroenterological Surgery, Graduate School of Medical Science, Kumamoto University, Kumamoto, JapanYoshifumi Baba, Department of Gastroenterological Surgery, Graduate School of Medical Science, Kumamoto University, Kumamoto, JapanMasayuki Watanabe, Department of Gastroenterological Surgery, Graduate School of Medical Science, Kumamoto University, Kumamoto, JapanHironobu Shigaki, Department of Gastroenterological Surgery, Graduate School of Medical Science, Kumamoto U...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5544132</comments>
            <pubDate>Wed, 21 Dec 2011 19:46:04 +0100</pubDate>
            <guid isPermaLink="false">5544132</guid>        </item>
        <item>
            <title>Posttherapy Nodal Status, Not Graded Histologic Response, Predicts Survival after Neoadjuvant Chemotherapy for Advanced Gastric Cancer</title>
            <link>http://www.medworm.com/index.php?rid=5544131&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F86n8p711k7020750%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Posttherapy nodal status, not graded histologic response, predicts survival after NAC for AGC and could serve as a reliable
 surrogate marker for OS in the course of exploring the most promising regimen for NAC.
 
 
 
 
	Content Type Journal ArticleCategory Gastrointestinal OncologyPages 1-8DOI 10.1245/s10434-011-2165-6Authors
		Kazumasa Fujitani, Department of Surgery, Osaka National Hospital, Osaka, JapanMasayuki Mano, Department of Pathology, Osaka National Hospital, Osaka, JapanMotohiro Hirao, Department of Surgery, Osaka National Hospital, Osaka, JapanYoshinori Kodama, Department of Pathology, Osaka National Hospital, Osaka, JapanToshimasa Tsujinaka, Department of Surgery, Osaka National Hospital, Osaka, Japan
	

	
		Journal Annals of Surgical OncologyOnline ISS...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5544131</comments>
            <pubDate>Wed, 21 Dec 2011 19:46:04 +0100</pubDate>
            <guid isPermaLink="false">5544131</guid>        </item>
        <item>
            <title>Safe Criteria for Less Radical Trachelectomy in Patients with Early-Stage Cervical Cancer: A Multicenter Clinicopathologic Study</title>
            <link>http://www.medworm.com/index.php?rid=5537457&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6n211p0pm57u1x78%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Less radical trachelectomy may be safe in patients with early-stage cervical cancer who have tumor size ≤1&amp;nbsp;cm.
 
 
 
	Content Type Journal ArticleCategory Gynecologic OncologyPages 1-7DOI 10.1245/s10434-011-2148-7Authors
		Hee Seung Kim, Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, KoreaChel Hun Choi, Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, KoreaMyong-Chul Lim, Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, Goyang, KoreaSuk-Joon Chang, Department of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, KoreaYong Beom Kim, Department of Obstetrics and Gynecology, Seoul National Univers...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5537457</comments>
            <pubDate>Tue, 20 Dec 2011 06:42:35 +0100</pubDate>
            <guid isPermaLink="false">5537457</guid>        </item>
        <item>
            <title>Loss of Heterozygosity at BRCA1 Locus Is Significantly Associated with Aggressiveness and Poor Prognosis in Breast Cancer</title>
            <link>http://www.medworm.com/index.php?rid=5524114&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F34n278678145827v%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;LOH at BRCA1 locus could be an independent prognostic biomarker useful in identifying a subgroup of patients with poor prognosis.
 
 
 
 
	Content Type Journal ArticleCategory Breast OncologyPages 1-9DOI 10.1245/s10434-011-2166-5Authors
		Satoko Okada, Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, JapanEriko Tokunaga, Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, JapanHiroyuki Kitao, Department of Molecular Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, JapanSayuri Akiyoshi, Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, JapanNami Yamashita, Department of Surgery and Science, Gradu...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5524114</comments>
            <pubDate>Sat, 17 Dec 2011 06:45:01 +0100</pubDate>
            <guid isPermaLink="false">5524114</guid>        </item>
        <item>
            <title>Number and Tumor Size Are Not Sufficient Criteria to Select Patients for Liver Transplantation for Hepatocellular Carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5524113&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk68098v7q4666v46%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Tumor size and VI were the only significant prognostic factors affecting survival of HCC patients. Primary liver resection
 could be a potential selection treatment before LT.
 
 
 
 
	Content Type Journal ArticleCategory Hepatobiliary TumorsPages 1-7DOI 10.1245/s10434-011-2170-9Authors
		T. Piardi, Pôle de Pathologie Digestive, Hépatique et de Transplantation, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, Université de Strasbourg, Strasbourg, FranceF. Gheza, Pôle de Pathologie Digestive, Hépatique et de Transplantation, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, Université de Strasbourg, Strasbourg, FranceB. Ellero, Pôle de Pathologie Digestive, Hépatique et de Transplantation, Hôpital de Hautepierre, Hôpitaux Unive...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5524113</comments>
            <pubDate>Sat, 17 Dec 2011 06:45:01 +0100</pubDate>
            <guid isPermaLink="false">5524113</guid>        </item>
        <item>
            <title>Scoring System Based on BI-RADS Lexicon to Predict Probability of Malignancy in Suspicious Microcalcifications</title>
            <link>http://www.medworm.com/index.php?rid=5515038&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk12951q1p725n734%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;In suspicious microcalcifications, our scoring system based on BI-RADS (4th edition) could help to derive a specific final
 category with good stratification of the probability of malignancy.
 
 
 
 
	Content Type Journal ArticleCategory Breast OncologyPages 1-8DOI 10.1245/s10434-011-2167-4Authors
		Ji Hyun Youk, Department of Radiology, Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul, South KoreaEun Ju Son, Department of Radiology, Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul, South KoreaJeong-Ah Kim, Department of Radiology, Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul, South KoreaHee Jung Moon, Department of Radiology, Research Institute...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515038</comments>
            <pubDate>Fri, 16 Dec 2011 06:53:48 +0100</pubDate>
            <guid isPermaLink="false">5515038</guid>        </item>
        <item>
            <title>Duodenal Adenocarcinoma: Clinicopathologic Analysis and Implications for Treatment</title>
            <link>http://www.medworm.com/index.php?rid=5515039&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa525q144h3077m77%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The prognostic significance of both the absolute number and ratio of involved lymph nodes emphasizes the need for adequate
 lymphadenectomy to accurately stage duodenal adenocarcinoma. The mostly distant pattern of recurrence underscores the need
 for the development of effective systemic therapies.
 
 
 
 
	Content Type Journal ArticleCategory Gastrointestinal OncologyPages 1-8DOI 10.1245/s10434-011-2168-3Authors
		George A. Poultsides, Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, MD, USALyen C. Huang, Department of Surgery, Stanford University School of Medicine, Stanford, CA, USAJohn L. Cameron, Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, MD, USARichard Tuli, Department of Radiation Oncology and Molecular Radiatio...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515039</comments>
            <pubDate>Wed, 14 Dec 2011 06:56:46 +0100</pubDate>
            <guid isPermaLink="false">5515039</guid>        </item>
        <item>
            <title>Endoscopic Therapy for Barrett’s Esophagus: A Review of Its Emerging Role in Optimal Diagnosis and Endoluminal Therapy</title>
            <link>http://www.medworm.com/index.php?rid=5515040&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2640632555h7k47m%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Barrett’s esophagus (BE) is a premalignant lesion known to sequentially progress to esophageal adenocarcinoma. Management
 of BE has changed significantly over the last 5&amp;nbsp;years with the development of endoscopic resection and ablation, which has
 replaced esophagectomy as the treatment of choice in BE with high-grade dysplasia. The aim of this review is to discuss the
 details of these new endotherapies in regards to response and durability and to define the role of these new therapies in
 the current management of BE.
 
 
	Content Type Journal ArticleCategory Gastrointestinal OncologyPages 1-8DOI 10.1245/s10434-011-2163-8Authors
		Erik M. Dunki-Jacobs, University of Louisville, Louisville, KY, USARobert C. G. Martin, University of Louisville, Louisville, KY, USA...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5515040</comments>
            <pubDate>Tue, 13 Dec 2011 06:57:50 +0100</pubDate>
            <guid isPermaLink="false">5515040</guid>        </item>
        <item>
            <title>Clinical and Self Breast Examination Remain Important in the Era of Modern Screening</title>
            <link>http://www.medworm.com/index.php?rid=5486421&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp1g5387285h01323%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Whereas the majority of patients had image-detected breast cancer, a significant number of image-screened patients presented
 with palpable disease, which were more aggressive cancers. Until imaging techniques are refined, SBE and CBE remain important
 for breast cancer diagnosis.
 
 
 
 
	Content Type Journal ArticleCategory Breast OncologyPages 1-7DOI 10.1245/s10434-011-2162-9Authors
		Irene Ma, Department of Surgery, Mayo Clinic Arizona, Phoenix, AZ, USAAmylou Dueck, Department of Biostatistics, Mayo Clinic Arizona, Phoenix, AZ, USARichard Gray, Department of Surgery, Mayo Clinic Arizona, Phoenix, AZ, USANabil Wasif, Department of Surgery, Mayo Clinic Arizona, Phoenix, AZ, USAMarina Giurescu, Department of Radiology, Mayo Clinic Arizona, Phoenix, AZ, USARoxanne Lo...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5486421</comments>
            <pubDate>Wed, 07 Dec 2011 17:33:23 +0100</pubDate>
            <guid isPermaLink="false">5486421</guid>        </item>
        <item>
            <title>Sentinel Node Biopsy in Early Gastric Cancer: Constant Exertion for Clinical Application</title>
            <link>http://www.medworm.com/index.php?rid=5486423&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ffn2g37112w060226%2F</link>
            <description>Content Type Journal ArticleCategory Gastrointestinal OncologyPages 1-2DOI 10.1245/s10434-011-2126-0Authors
		Han-Kwang Yang, Department of Surgery &amp; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
	

	
		Journal Annals of Surgical OncologyOnline ISSN 1534-4681Print ISSN 1068-9265 (Source: Annals of Surgical Oncology)</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5486423</comments>
            <pubDate>Wed, 07 Dec 2011 10:50:51 +0100</pubDate>
            <guid isPermaLink="false">5486423</guid>        </item>
        <item>
            <title>Oncology Health Information Quality on the Internet: a Multilingual Evaluation</title>
            <link>http://www.medworm.com/index.php?rid=5486422&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0l74881243457680%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;A lack of validation of most oncologic sites is present, with discrepancies in the quality and number of Web sites across
 diseases and languages, as well as medical and alternative terms. Physicians should encourage and participate in the development
 of informative, ethical, and reliable health Web sites on the Internet and direct patients to them.
 
 
 
 
	Content Type Journal ArticleCategory Healthcare Policy and OutcomesPages 1-8DOI 10.1245/s10434-011-2137-xAuthors
		Nathan Lawrentschuk, Ludwig Institute for Cancer Research, Austin Hospital, Melbourne, AustraliaDeborah Sasges, Department of Surgical Oncology, Princess Margaret Hospital, University of Toronto, Toronto, CanadaRobert Tasevski, Department of Surgical Oncology, Princess Margaret Hospital, University ...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5486422</comments>
            <pubDate>Wed, 07 Dec 2011 10:50:51 +0100</pubDate>
            <guid isPermaLink="false">5486422</guid>        </item>
        <item>
            <title>SIRT1 Promotes Tumorigenesis and Resistance to Chemotherapy in Hepatocellular Carcinoma and its Expression Predicts Poor Prognosis</title>
            <link>http://www.medworm.com/index.php?rid=5486424&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr4016441qg344522%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;SIRT1 is an oncogenic protein for HCC and is a predictor of worse outcome after surgical resection of HCC.
 
 
 
	Content Type Journal ArticleCategory Hepatobiliary TumorsPages 1-9DOI 10.1245/s10434-011-2159-4Authors
		Hsieh-Cheng Chen, Graduate Institute of Pathology, National Taiwan University, Taipei, TaiwanYung-Ming Jeng, Graduate Institute of Pathology, National Taiwan University, Taipei, TaiwanRay-Hwang Yuan, Department of Surgery, National Taiwan University Hospital, Taipei, TaiwanHey-Chi Hsu, Graduate Institute of Pathology, National Taiwan University, Taipei, TaiwanYu-Ling Chen, Graduate Institute of Pathology, National Taiwan University, Taipei, Taiwan
	

	
		Journal Annals of Surgical OncologyOnline ISSN 1534-4681Print ISSN 1068-9265 (Source: Annals of Sur...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5486424</comments>
            <pubDate>Tue, 06 Dec 2011 19:09:43 +0100</pubDate>
            <guid isPermaLink="false">5486424</guid>        </item>
        <item>
            <title>Comparison between Preoperative Versus Intraoperative Injection of Technetium-99 m Neomannosyl Human Serum Albumin for Sentinel Lymph Node Identification in Early Stage Lung Cancer</title>
            <link>http://www.medworm.com/index.php?rid=5486425&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F55359485v3351273%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Sentinel node identification using 99mTc-MSA appears to provide similar excellent results in both preoperative and intraoperative injection. Therefore, intraoperative
 injection of 99mTc-MSA may be preferred as a result of lower cost and less waste of time.
 
 
 
 
	Content Type Journal ArticleCategory Thoracic OncologyPages 1-7DOI 10.1245/s10434-011-2130-4Authors
		Hyun Koo Kim, Department of Thoracic and Cardiovascular Surgery, Korea University Guro Hospital, Korea University College of Medicine, Seoul, KoreaSungeun Kim, Department of Nuclear Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, KoreaHo Kyung Sung, Department of Thoracic and Cardiovascular Surgery, Korea University Guro Hospital, Korea University College of Medicine...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5486425</comments>
            <pubDate>Tue, 06 Dec 2011 07:01:10 +0100</pubDate>
            <guid isPermaLink="false">5486425</guid>        </item>
        <item>
            <title>Surveillance of Pancreatic Cancer Patients after Surgical Resection</title>
            <link>http://www.medworm.com/index.php?rid=5486427&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk212t600k6v6x152%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Current surveillance patterns after resection for pancreatic cancer reflect the lack of established guidelines, implying a
 need for evaluation and standardization of surveillance protocols. The lack of a temporal pattern in CT testing suggests that
 most were obtained to evaluate symptoms rather than for routine surveillance.
 
 
 
 
	Content Type Journal ArticleCategory Pancreatic TumorsPages 1-8DOI 10.1245/s10434-011-2152-yAuthors
		Kristin M. Sheffield, Department of Surgery, The University of Texas Medical Branch, Galveston, TX, USAKristen T. Crowell, Department of Surgery, The University of Texas Medical Branch, Galveston, TX, USAYu-Li Lin, Sealy Center on Aging, The University of Texas Medical Branch, Galveston, TX, USAClarisse Djukom, Department of Surgery, T...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5486427</comments>
            <pubDate>Tue, 06 Dec 2011 07:01:09 +0100</pubDate>
            <guid isPermaLink="false">5486427</guid>        </item>
        <item>
            <title>Risk Factors for Peritoneal Recurrence in Stage II/III Gastric Cancer Patients Who Received S-1 Adjuvant Chemotherapy After D2 Gastrectomy</title>
            <link>http://www.medworm.com/index.php?rid=5486426&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc454v25587136jt0%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The macroscopic tumor diameter and presence of lymph node metastasis were the most important risk factors for peritoneal recurrence.
 When patients had these risk factors, S-1 was not sufficient to inhibit peritoneal recurrence. A novel adjuvant chemotherapeutic
 agent targeting peritoneal metastasis in these patients should be developed.
 
 
 
 
	Content Type Journal ArticleCategory Gastrointestinal OncologyPages 1-7DOI 10.1245/s10434-011-2158-5Authors
		Toru Aoyama, Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, JapanTakaki Yoshikawa, Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, JapanTsutomu Hayashi, Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, JapanHiroshi Kuwabara, Department of ...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5486426</comments>
            <pubDate>Tue, 06 Dec 2011 07:01:09 +0100</pubDate>
            <guid isPermaLink="false">5486426</guid>        </item>
        <item>
            <title>A Multi-institutional Experience of Repeat Regional Chemotherapy for Recurrent Melanoma of Extremities</title>
            <link>http://www.medworm.com/index.php?rid=5486428&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb135856717727116%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Most patients tolerated repeat regional chemotherapy without increased toxicity or LOS. No statistical difference in clinical
 outcomes was noted when comparing repeat procedures, even though repeat HILPs showed higher complete response compared to
 repeat ILIs.
 
 
 
 
	Content Type Journal ArticleCategory MelanomasPages 1-7DOI 10.1245/s10434-011-2151-zAuthors
		Christy Y. Chai, Department of Surgery, San Antonio Military Medical Center, San Antonio, TX, USAJeremiah L. Deneve, Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USAGeorgia M. Beasley, Department of Surgery, Duke University, Durham, NC, USASuroosh S. Marzban, Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USAY. Ann Chen, Department of Biostatistics, Moffitt Cancer ...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5486428</comments>
            <pubDate>Tue, 06 Dec 2011 07:01:08 +0100</pubDate>
            <guid isPermaLink="false">5486428</guid>        </item>
        <item>
            <title>Adenocarcinomas of the Esophagogastric Junction Are More Likely to Respond to Preoperative Chemotherapy than Distal Gastric Cancer</title>
            <link>http://www.medworm.com/index.php?rid=5476143&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff43449170x046873%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;AEG is more likely to respond to preoperative chemotherapy than GC, a finding that might help identify patients who would
 benefit from preoperative chemotherapy.
 
 
 
 
	Content Type Journal ArticleCategory Gastrointestinal OncologyPages 1-11DOI 10.1245/s10434-011-2147-8Authors
		Daniel Reim, Department of Surgery, Klinikum rechts der Isar, Technische Universität München, Munich, GermanyRalf Gertler, Department of Surgery, Klinikum rechts der Isar, Technische Universität München, Munich, GermanyAlexander Novotny, Department of Surgery, Klinikum rechts der Isar, Technische Universität München, Munich, GermanyKaren Becker, Department of Pathology, Klinikum rechts der Isar, Technische Universität München, Munich, GermanyChristian Meyer zum Büschenfelde, Depar...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5476143</comments>
            <pubDate>Wed, 30 Nov 2011 18:52:38 +0100</pubDate>
            <guid isPermaLink="false">5476143</guid>        </item>
        <item>
            <title>DOK2 as a Marker of Poor Prognosis of Patients with Gastric Adenocarcinoma After Curative Resection</title>
            <link>http://www.medworm.com/index.php?rid=5476145&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd337x47663351170%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Our data suggest the potential usefulness of DOK2 as a marker of poor prognosis in patients with gastric cancer after curative
 resection.
 
 
 
 
	Content Type Journal ArticleCategory Gastrointestinal OncologyPages 1-8DOI 10.1245/s10434-011-2157-6Authors
		Hiromichi Miyagaki, Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, JapanMakoto Yamasaki, Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, JapanTsuyoshi Takahashi, Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, JapanYukinori Kurokawa, Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, JapanHiroshi Miyata, Department of Gastroent...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5476145</comments>
            <pubDate>Wed, 30 Nov 2011 18:52:36 +0100</pubDate>
            <guid isPermaLink="false">5476145</guid>        </item>
        <item>
            <title>Changes in Age, Stage Distribution, and Survival of Patients with Esophageal Adenocarcinoma over Three Decades in the United States</title>
            <link>http://www.medworm.com/index.php?rid=5476144&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm423544j93464611%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;There has been a substantial improvement in overall survival among patients with invasive EAC over the last 3 decades. Patients
 receiving esophagectomy had longer survival. Survival with esophagectomy improved in each time period. Although younger EAC
 patients were diagnosed at more advanced stages over time, they had better survival.
 
 
 
 
	Content Type Journal ArticleCategory Thoracic OncologyPages 1-7DOI 10.1245/s10434-011-2141-1Authors
		Putao Cen, Division of Oncology, Department of Internal Medicine, The University of Texas Medical School at Houston, Houston, TX, USAFarzaneh Banki, Department of Cardiothoracic and Vascular Surgery, The University of Texas Medical School at Houston, Houston, TX, USALee Cheng, Department of Biostatistics, School of Public Hea...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5476144</comments>
            <pubDate>Wed, 30 Nov 2011 18:52:36 +0100</pubDate>
            <guid isPermaLink="false">5476144</guid>        </item>
        <item>
            <title>Downstaging in Pancreatic Cancer: A Matched Analysis of Patients Resected Following Systemic Treatment of Initially Locally Unresectable Disease</title>
            <link>http://www.medworm.com/index.php?rid=5468390&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm1367j5583627l25%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;In this study, patients who were able to undergo resection following treatment of initial stage III pancreatic cancer experienced
 survival similar to those who were initially resectable. Resection is indicated in this highly select group of patients.
 
 
 
 
	Content Type Journal ArticleCategory Pancreatic TumorsPages 1-7DOI 10.1245/s10434-011-2156-7Authors
		K. A. Bickenbach, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY, USAM. Gonen, Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USALaura H. Tang, Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USAEileen O’Reilly, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New Yor...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5468390</comments>
            <pubDate>Wed, 30 Nov 2011 18:52:36 +0100</pubDate>
            <guid isPermaLink="false">5468390</guid>        </item>
        <item>
            <title>Lymphatic Vessels and High Endothelial Venules are Increased in the Sentinel Lymph Nodes of Patients with Oral Squamous Cell Carcinoma Before the Arrival of Tumor Cells</title>
            <link>http://www.medworm.com/index.php?rid=5468391&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3kuk152v8v7w2237%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Lymphatic vessels and HEVs were increased in SLNs, regardless of metastatic status of SLNs. Vascular endothelial growth factor
 C expression of primary tumor may contribute to the premetastatic change within SLNs of oral squamous cell carcinoma.
 
 
 
 
	Content Type Journal ArticleCategory Head and Neck OncologyPages 1-7DOI 10.1245/s10434-011-2154-9Authors
		Man Ki Chung, Department of Otorhinolaryngology-Head and Neck Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Republic of KoreaIn-Gu Do, Department of Pathology, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Republic of KoreaEunwook Jung, Department of Otorhinolaryngology-Head and Neck Surgery, Sungkyunkwan University School of Medicine, Samsung Me...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5468391</comments>
            <pubDate>Tue, 29 Nov 2011 22:19:59 +0100</pubDate>
            <guid isPermaLink="false">5468391</guid>        </item>
        <item>
            <title>Prognostic Value of Preoperative Metabolic Tumor Volume and Total Lesion Glycolysis in Patients with Epithelial Ovarian Cancer</title>
            <link>http://www.medworm.com/index.php?rid=5468392&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh75432k52n11j5xl%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Pretreatment metabolic parameters such as MTV and TLG showed statistically significant association with recurrence in patients
 with EOC. These values can be useful quantitative criteria for disease prognostication in patients with EOC before treatment.
 
 
 
 
	Content Type Journal ArticleCategory Gynecologic OncologyPages 1-7DOI 10.1245/s10434-011-2153-xAuthors
		Hyun Hoon Chung, Department of Obstetrics and Gynecology, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of KoreaHyun Woo Kwon, Department of Nuclear Medicine, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of KoreaKeon Wook Kang, Department of Nuclear Medicine, Cancer Research Institute, Seoul National University College...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5468392</comments>
            <pubDate>Tue, 29 Nov 2011 22:19:56 +0100</pubDate>
            <guid isPermaLink="false">5468392</guid>        </item>
        <item>
            <title>Combined Hepatocellular–Cholangiocarcinoma Had Poor Outcomes after Hepatectomy Regardless of Allen and Lisa Class or the Predominance of Intrahepatic Cholangiocarcinoma Cells within the Tumor</title>
            <link>http://www.medworm.com/index.php?rid=5449507&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fpq0wr2t4720k3522%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;CHC had poor outcomes after hepatectomy regardless of Allen and Lisa class or the predominance of ICC cells within the tumor.
 
 
 
	Content Type Journal ArticleCategory Hepatobiliary TumorsPages 1-9DOI 10.1245/s10434-011-2150-0Authors
		Shun-ichi Ariizumi, Department of Surgery, Institute of Gastroenterology, Tokyo Women’s Medical University, Tokyo, JapanYoshihito Kotera, Department of Surgery, Institute of Gastroenterology, Tokyo Women’s Medical University, Tokyo, JapanSatoshi Katagiri, Department of Surgery, Institute of Gastroenterology, Tokyo Women’s Medical University, Tokyo, JapanMasayuki Nakano, Division of Pathology, Ofuna Chuo Hospital, Kanagawa, JapanMasakazu Yamamoto, Department of Surgery, Institute of Gastroenterology, Tokyo Women’s Medical Univ...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5449507</comments>
            <pubDate>Thu, 24 Nov 2011 06:50:50 +0100</pubDate>
            <guid isPermaLink="false">5449507</guid>        </item>
        <item>
            <title>Six-Year Analysis of Treatment-Related Toxicities in Patients Treated with Accelerated Partial Breast Irradiation on the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial</title>
            <link>http://www.medworm.com/index.php?rid=5449508&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F82212185581rk062%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Treatment-related toxicities 6&amp;nbsp;years after treatment with APBI using the MammoSite device are similar to those reported with
 other forms of APBI with similar follow-up.
 
 
 
 
	Content Type Journal ArticleCategory Breast OncologyPages 1-7DOI 10.1245/s10434-011-2133-1Authors
		A. J. Khan, Department of Radiation Oncology, Cancer Institute of New Jersey, New Brunswick, NJ, USADouglas Arthur, Department of Radiation Oncology, Virginia Commonwealth University, Richmond, VA, USAF. Vicini, Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, USAP. Beitsch, Department of Surgery, Dallas Breast Center, Dallas, TX, USAH. Kuerer, Department of Surgery, M. D. Anderson Cancer Center, Houston, TX, USAS. Goyal, Department of Radiation Oncology, Cancer...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5449508</comments>
            <pubDate>Wed, 23 Nov 2011 16:40:52 +0100</pubDate>
            <guid isPermaLink="false">5449508</guid>        </item>
        <item>
            <title>Staging of Regional Nodes in Pulmonary Malignancies</title>
            <link>http://www.medworm.com/index.php?rid=5449510&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F76n1225m27461216%2F</link>
            <description>Content Type Journal ArticleCategory Thoracic OncologyPages 1-3DOI 10.1245/s10434-011-2146-9Authors
		Mark B. Faries, Department of Surgical Oncology, John Wayne Cancer Institute at Saint John’s Health Center, Santa Monica, CA, USADonald L. Morton, Department of Surgical Oncology, John Wayne Cancer Institute at Saint John’s Health Center, Santa Monica, CA, USA
	

	
		Journal Annals of Surgical OncologyOnline ISSN 1534-4681Print ISSN 1068-9265 (Source: Annals of Surgical Oncology)</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5449510</comments>
            <pubDate>Wed, 23 Nov 2011 16:40:51 +0100</pubDate>
            <guid isPermaLink="false">5449510</guid>        </item>
        <item>
            <title>Can the Beast Be Tamed? The Woeful Tale of Accurate Health Information on the Internet</title>
            <link>http://www.medworm.com/index.php?rid=5449509&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff057k13777232v06%2F</link>
            <description>Content Type Journal ArticleCategory Healthcare Policy and OutcomesPages 1-2DOI 10.1245/s10434-011-2139-8Authors
		J. Leonard Lichtenfeld, Office of the Deputy Chief Medical Officer, National Home Office, American Cancer Society, Atlanta, GA, USA
	

	
		Journal Annals of Surgical OncologyOnline ISSN 1534-4681Print ISSN 1068-9265 (Source: Annals of Surgical Oncology)</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5449509</comments>
            <pubDate>Wed, 23 Nov 2011 16:40:51 +0100</pubDate>
            <guid isPermaLink="false">5449509</guid>        </item>
        <item>
            <title>Sentinel Node Navigation Surgery by Thoracoscopic Fluorescence Imaging System and Molecular Examination in Non-Small Cell Lung Cancer</title>
            <link>http://www.medworm.com/index.php?rid=5431340&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg1h5758n0lh62137%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;These results demonstrated that thoracoscopic ICG fluorescence imaging-guided surgery and real-time quantitative RT-PCR were
 useful for sentinel node biopsy and might be a powerful tool for more focused pathologic or molecular evaluation for staging.
 
 
 
 
	Content Type Journal ArticleCategory Thoracic OncologyPages 1-6DOI 10.1245/s10434-011-2145-xAuthors
		Shin-ichi Yamashita, Department of Surgery II, Faculty of Medicine, Oita University, Oita, JapanKeita Tokuishi, Department of Surgery II, Faculty of Medicine, Oita University, Oita, JapanMichiyo Miyawaki, Department of Surgery II, Faculty of Medicine, Oita University, Oita, JapanKentaro Anami, Department of Surgery II, Faculty of Medicine, Oita University, Oita, JapanToshihiko Moroga, Department of Surgery II, ...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5431340</comments>
            <pubDate>Sat, 19 Nov 2011 06:50:42 +0100</pubDate>
            <guid isPermaLink="false">5431340</guid>        </item>
        <item>
            <title>Right Paraesophageal Lymph Node Dissection in Papillary Thyroid Carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5431341&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7p83271q88017n61%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;RPELN dissection should be considered in patients with right thyroid cancer, tumors larger than 1&amp;nbsp;cm, or multiple CLN metastases.
 
 
 
	Content Type Journal ArticleCategory Head and Neck OncologyPages 1-5DOI 10.1245/s10434-011-2144-yAuthors
		Soo Youn Bae, Department of Surgery, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Republic of KoreaJung-Hyun Yang, Department of Surgery, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Republic of KoreaMin-Young Choi, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaJun-Ho Choe, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaJ...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5431341</comments>
            <pubDate>Fri, 18 Nov 2011 06:55:56 +0100</pubDate>
            <guid isPermaLink="false">5431341</guid>        </item>
        <item>
            <title>Circulating CD133: A Promising Biomarker, but What Are We Measuring?</title>
            <link>http://www.medworm.com/index.php?rid=5431342&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw134014241gj620p%2F</link>
            <description>Content Type Journal ArticleCategory Colorectal CancerPages 1-2DOI 10.1245/s10434-011-2135-zAuthors
		Michael I. D’Angelica, Department of Surgery, Hepatopancreatobiliary Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
	

	
		Journal Annals of Surgical OncologyOnline ISSN 1534-4681Print ISSN 1068-9265 (Source: Annals of Surgical Oncology)</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5431342</comments>
            <pubDate>Fri, 18 Nov 2011 06:55:55 +0100</pubDate>
            <guid isPermaLink="false">5431342</guid>        </item>
        <item>
            <title>Feasibility of Surgery After Systemic Treatment with the Humanized Recombinant Antibody Bevacizumab in Heavily Pretreated Patients with Advanced Epithelial Ovarian Cancer</title>
            <link>http://www.medworm.com/index.php?rid=5431343&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq457264777802807%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Emergency surgery after BT due to bowel obstruction and/or fistulas seems to be associated with an impaired wound healing
 in advanced heavily pretreated platinum-resistant OC patients, while this does not appear the case in planned cytoreduction.
 Prospective evaluations are warranted to assess surgical safety after BT in this special patients’ collective.
 
 
 
 
	Content Type Journal ArticleCategory Gynecologic OncologyPages 1-8DOI 10.1245/s10434-011-2134-0Authors
		Jalid Sehouli, Department of Gynecology, European Competence Centre for Ovarian Cancer, Charité-University Hospital, Berlin, GermanyG. Papanikolaou, Department of Gynecology, European Competence Centre for Ovarian Cancer, Charité-University Hospital, Berlin, GermanyE.-I. Braicu, Department of Gynec...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5431343</comments>
            <pubDate>Thu, 17 Nov 2011 06:58:25 +0100</pubDate>
            <guid isPermaLink="false">5431343</guid>        </item>
        <item>
            <title>Transient but Not Stable ZEB1 Knockdown Dramatically Inhibits Growth of Malignant Pleural Mesothelioma Cells</title>
            <link>http://www.medworm.com/index.php?rid=5421586&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6035u51944453042%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;RNA interference-mediated ZEB1 knockdown may be a promising therapeutic strategy for MPM, but one has to consider the possibility of diminished growth inhibitory
 effects of long-term ZEB1 knockdown, possibly as a result of EpCAM up-regulation and/or other gene expression changes resulting from ZEB1 knockdown.
 
 
 
 
	Content Type Journal ArticleCategory Translational Research and BiomarkersPages 1-12DOI 10.1245/s10434-011-2142-0Authors
		Mihoko Horio, Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, JapanMitsuo Sato, Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, JapanYoshihiro Takeyama, Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Jap...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5421586</comments>
            <pubDate>Wed, 16 Nov 2011 06:50:01 +0100</pubDate>
            <guid isPermaLink="false">5421586</guid>        </item>
        <item>
            <title>Laparoscopic Staging of Early Ovarian Cancer: Results of a Multi-Institutional Cohort Study</title>
            <link>http://www.medworm.com/index.php?rid=5421585&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe233t1264l77142k%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;When performed by appropriately skilled surgeons, laparoscopic comprehensive staging of EOC seems feasible and adequate, with
 surgicopathologic results that are reproducible in different practice settings.
 
 
 
 
	Content Type Journal ArticleCategory Gynecologic OncologyPages 1-6DOI 10.1245/s10434-011-2138-9Authors
		Fabio Ghezzi, Gynecologic Oncology Unit, University of Insubria, Varese, ItalyMario Malzoni, Advanced Gynecological Endoscopy Center, Malzoni Medical Center, Avellino, ItalyEnrico Vizza, National Cancer Institute Regina Elena, Rome, ItalyAntonella Cromi, Gynecologic Oncology Unit, University of Insubria, Varese, ItalyCiro Perone, Advanced Gynecological Endoscopy Center, Malzoni Medical Center, Avellino, ItalyGiacomo Corrado, National Cancer Institute R...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5421585</comments>
            <pubDate>Wed, 16 Nov 2011 06:50:01 +0100</pubDate>
            <guid isPermaLink="false">5421585</guid>        </item>
        <item>
            <title>Combined Analysis of Dihydropyrimidine Dehydrogenase and Human Equilibrative Nucleoside Transporter 1 Expression Predicts Survival of Pancreatic Carcinoma Patients Treated with Adjuvant Gemcitabine Plus S-1 Chemotherapy after Surgical Resection</title>
            <link>http://www.medworm.com/index.php?rid=5421584&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fnh17269181168k14%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Combined analysis of DPD and hENT1 expression predicts the survival of PDAC patients treated with adjuvant GEM+S-1 chemotherapy.
 
 
 
	Content Type Journal ArticleCategory Translational Research and BiomarkersPages 1-10DOI 10.1245/s10434-011-2140-2Authors
		Naru Kondo, Division of Clinical Medical Science, Department of Surgery, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, JapanYoshiaki Murakami, Division of Clinical Medical Science, Department of Surgery, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, JapanKenichiro Uemura, Division of Clinical Medical Science, Department of Surgery, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, JapanTakeshi Sudo, Division of Clinical Medical Science, ...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5421584</comments>
            <pubDate>Wed, 16 Nov 2011 06:50:01 +0100</pubDate>
            <guid isPermaLink="false">5421584</guid>        </item>
        <item>
            <title>Ethical Considerations in Clinical Research</title>
            <link>http://www.medworm.com/index.php?rid=5421587&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm02n885123p35jr2%2F</link>
            <description>Content Type Journal ArticleCategory Healthcare Policy and OutcomesPages 1-2DOI 10.1245/s10434-011-2143-zAuthors
		Emily C. Bellavance, Division of Surgical Oncology, Department of Surgery, University of Maryland School of Medicine, Baltimore, MarylandH. R. Alexander, Division of Surgical Oncology, Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland
	

	
		Journal Annals of Surgical OncologyOnline ISSN 1534-4681Print ISSN 1068-9265 (Source: Annals of Surgical Oncology)</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5421587</comments>
            <pubDate>Wed, 16 Nov 2011 06:49:59 +0100</pubDate>
            <guid isPermaLink="false">5421587</guid>        </item>
        <item>
            <title>Comparison of Single-Port Laparoscopy, Standard Laparoscopy, and Robotic Surgery in Patients with Endometrial Cancer</title>
            <link>http://www.medworm.com/index.php?rid=5421588&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F5p23387163137754%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Our findings suggest SPL surgery for endometrial carcinoma is feasible with similar operating times, hospital length of stay,
 complication rates, and estimated blood loss when compared with laparoscopy and robotics.
 
 
 
 
	Content Type Journal ArticleCategory Gynecologic OncologyPages 1-6DOI 10.1245/s10434-011-2136-yAuthors
		Pedro F. Escobar, Section of Gynecologic Oncology, Cleveland Clinic, Cleveland, OH, USAMichael Frumovitz, Department of Gynecologic Oncology, MD Anderson Cancer Center, Houston, TX, USAPamela T. Soliman, Department of Gynecologic Oncology, MD Anderson Cancer Center, Houston, TX, USAHeidi E. Frasure, University Hospitals of Cleveland, Cleveland, OH, USAAmanda Nickles Fader, Section of Gynecologic Oncology, Greater Baltimore Medical Center/John...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5421588</comments>
            <pubDate>Tue, 15 Nov 2011 06:48:17 +0100</pubDate>
            <guid isPermaLink="false">5421588</guid>        </item>
        <item>
            <title>Prognostic Value of Putative Circulating Cancer Stem Cells in Patients Undergoing Hepatic Resection for Colorectal Liver Metastasis</title>
            <link>http://www.medworm.com/index.php?rid=5407092&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft420492m3w4g118h%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;CD133-positive CTC may represent a suitable prognostic marker to stratify the risk of patients who undergo liver resection
 for CRC metastasis, which opens the avenue to identifying and potentially monitoring the patients who are most likely to benefit
 from adjuvant treatments.
 
 
 
 
	Content Type Journal ArticleCategory Colorectal CancerPages 1-7DOI 10.1245/s10434-011-2132-2Authors
		Pierluigi Pilati, Surgery Branch, Department of Oncological and Surgical Sciences, University of Padova, Padova, ItalySimone Mocellin, Surgery Branch, Department of Oncological and Surgical Sciences, University of Padova, Padova, ItalyLoris Bertazza, Surgery Branch, Department of Oncological and Surgical Sciences, University of Padova, Padova, ItalyFrancesca Galdi, Surgery Branch, De...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5407092</comments>
            <pubDate>Thu, 10 Nov 2011 06:45:50 +0100</pubDate>
            <guid isPermaLink="false">5407092</guid>        </item>
        <item>
            <title>Robot-Assisted Transaxillary Thyroid Surgery in the United States: Is it Comparable to Open Thyroid Lobectomy?</title>
            <link>http://www.medworm.com/index.php?rid=5407094&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F92nq3w758660l587%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;In a select group of patients, RATS is comparable to open thyroid lobectomy in terms of postoperative complications and hospital
 stay. Patients should be counseled that RATS is associated with a longer operative time, a potential for brachial plexus neurological
 deficits, and larger (although still low) blood loss. A prospective trial further evaluating cost, quality of life, and patient-reported
 satisfaction is warranted.
 
 
 
 
	Content Type Journal ArticleCategory Endocrine TumorsPages 1-6DOI 10.1245/s10434-011-2075-7Authors
		Christine S. Landry, Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USAElizabeth G. Grubbs, Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houst...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5407094</comments>
            <pubDate>Tue, 08 Nov 2011 06:47:24 +0100</pubDate>
            <guid isPermaLink="false">5407094</guid>        </item>
        <item>
            <title>Patterns of Care, Prognosis, and Survival in Patients with Metastatic Gastrointestinal Stromal Tumors (GIST) Refractory to First-Line Imatinib and Second-Line Sunitinib</title>
            <link>http://www.medworm.com/index.php?rid=5407093&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2w51006g26k6m361%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;In the 3rd-line setting, rechallenge with imatinib provided limited clinical benefit but was superior to BSC. Sorafenib and
 nilotinib have significant clinical activity in imatinib-resistant and sunitinib-resistant GIST and may represent an alternative
 for rechallenge with imatinib.
 
 
 
 
	Content Type Journal ArticleCategory Gastrointestinal OncologyPages 1-9DOI 10.1245/s10434-011-2120-6Authors
		Antoine Italiano, Institut Bergonié, Bordeaux, FranceAngela Cioffi, Memorial Sloan Kettering Cancer Center, New York, USAPaola Coco, Istituto dei Tumori, Milan, ItalyRobert G. Maki, Memorial Sloan Kettering Cancer Center, New York, USAPatrick Schöffski, Department of General Medical Oncology and Laboratory of Experimental Oncology, University Hospitals Leuven, Leuven C...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5407093</comments>
            <pubDate>Tue, 08 Nov 2011 06:47:24 +0100</pubDate>
            <guid isPermaLink="false">5407093</guid>        </item>
        <item>
            <title>Adverse Effects of Smoking on Postoperative Outcomes in Cancer Patients</title>
            <link>http://www.medworm.com/index.php?rid=5407095&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F15t477814j608874%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Prior and current smoking status is a significant risk factor for major postoperative complications and mortality following
 GI cancer and thoracic operations in veterans. Smoking cessation should be encouraged prior to all major cancer surgery in
 the VA population to decrease postoperative complications and length of stay.
 
 
 
 
	Content Type Journal ArticleCategory Healthcare Policy and OutcomesPages 1-9DOI 10.1245/s10434-011-2128-yAuthors
		Csaba Gajdos, Department of Surgery, University of Colorado at Denver, Denver, CO, USAMary T. Hawn, The Center for Surgical, Medical Acute Care Research and Transitions (C-SMART), Birmingham Veterans Affairs Hospital, Birmingham, AL, USAElizabeth J. Campagna, The Center for Surgical, Medical Acute Care Research and Transitio...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5407095</comments>
            <pubDate>Tue, 08 Nov 2011 06:47:23 +0100</pubDate>
            <guid isPermaLink="false">5407095</guid>        </item>
        <item>
            <title>Aggressive Variants of Papillary Thyroid Cancer: Incidence, Characteristics and Predictors of Survival among 43,738 Patients</title>
            <link>http://www.medworm.com/index.php?rid=5407096&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8158581m594hp743%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;DSV and TCV are rare, increasing in incidence, and have a worse prognosis than classic PTC. Patients with these variants should
 be treated aggressively with thyroidectomy and radioiodine, regardless of tumor size.
 
 
 
 
	Content Type Journal ArticleCategory Endocrine TumorsPages 1-7DOI 10.1245/s10434-011-2129-xAuthors
		Hadiza S. Kazaure, Department of Surgery, Yale University School of Medicine, New Haven, CT, USASanziana A. Roman, Department of Surgery, Yale University School of Medicine, New Haven, CT, USAJulie A. Sosa, Department of Surgery, Yale University School of Medicine, New Haven, CT, USA
	

	
		Journal Annals of Surgical OncologyOnline ISSN 1534-4681Print ISSN 1068-9265 (Source: Annals of Surgical Oncology)</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5407096</comments>
            <pubDate>Tue, 08 Nov 2011 06:47:21 +0100</pubDate>
            <guid isPermaLink="false">5407096</guid>        </item>
        <item>
            <title>Molecular Detection of Sentinel Node Micrometastases in Patients with Clinical N0 Gastric Carcinoma with Real-time Multiplex Reverse Transcription-Polymerase Chain Reaction Assay</title>
            <link>http://www.medworm.com/index.php?rid=5407097&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff426333064365344%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The real-time multiplex RT-PCR assay is a useful tool for the detection of MM in SNs and NSNs in patients with gastric cancer.
 
 
 
	Content Type Journal ArticleCategory Gastrointestinal OncologyPages 1-9DOI 10.1245/s10434-011-2122-4Authors
		Yoshimasa Shimizu, Department of Surgery, Keio University School of Medicine, Tokyo, JapanHiroya Takeuchi, Department of Surgery, Keio University School of Medicine, Tokyo, JapanYasuhiko Sakakura, Molecular Diagnostics R&amp;D Department, Roche Diagnostics K.K., Tokyo, JapanYoshiro Saikawa, Department of Surgery, Keio University School of Medicine, Tokyo, JapanTadaki Nakahara, Department of Radiology, Keio University School of Medicine, Tokyo, JapanMakio Mukai, Department of Pathology, Keio University School of Medicine, Tokyo, Jap...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5407097</comments>
            <pubDate>Tue, 08 Nov 2011 06:47:20 +0100</pubDate>
            <guid isPermaLink="false">5407097</guid>        </item>
        <item>
            <title>Survivin T9809C, an SNP Located in 3′-UTR, Displays a Correlation with the Risk and Clinicopathological Development of Hepatocellular Carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5384536&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F74156607672nm6g4%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;
 Survivin +9809 polymorphic genotype is associated with the risk of HCC, and the HCC patients with survivin +9809 CC homozygotes might have a low risk of developing infected HCV-dependent HCC. The results suggest that the survivin T9809C SNP might contribute to the prediction of susceptibility and pathological development to HCC.
 
 
 
 
	Content Type Journal ArticleCategory Translational Research and BiomarkersPages 1-9DOI 10.1245/s10434-011-2123-3Authors
		Yih-Shou Hsieh, Institute of Biochemistry and Biotechnology, Chung Shan Medical University, Taichung, TaiwanChiung-Man Tsai, Hualien Hospital, Department of Health, Executive Yuan, Hualien City, Hualien County, TaiwanChao-Bin Yeh, School of Medicine, Chung Shan Medical University, Taichung, TaiwanShun-Fa Yang, I...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5384536</comments>
            <pubDate>Fri, 04 Nov 2011 05:42:39 +0100</pubDate>
            <guid isPermaLink="false">5384536</guid>        </item>
        <item>
            <title>Myxoid\Round Cell Liposarcoma (MRCLS) Revisited: An Analysis of 418 Primarily Managed Cases</title>
            <link>http://www.medworm.com/index.php?rid=5384537&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fkk0hpq04558x2806%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;MLS and RCLS showed different metastatic risk but equally good local control. Radiotherapy was effective in preventing local
 recurrence and should be delivered as neoadjuvant. New staging strategies are to be defined to account for the unusual metastatic
 pattern.
 
 
 
 
	Content Type Journal ArticleCategory Bone and Soft Tissue SarcomasPages 1-8DOI 10.1245/s10434-011-2127-zAuthors
		Louis-Charles Moreau, Orthopaedic Surgery, McGill University Health Centre, Montreal, Quebec, CanadaRobert Turcotte, Orthopaedic Surgery, McGill University Health Centre, Montreal, Quebec, CanadaPeter Ferguson, Orthopaedic Surgery, Mount Sinai Hospital, Toronto, Ontario, CanadaJay Wunder, Orthopaedic Surgery, Mount Sinai Hospital, Toronto, Ontario, CanadaPaul Clarkson, Orthopaedics, Un...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5384537</comments>
            <pubDate>Thu, 03 Nov 2011 16:54:25 +0100</pubDate>
            <guid isPermaLink="false">5384537</guid>        </item>
        <item>
            <title>Erratum to: What is the Significance of the In Transit or Interval Sentinel Node in Melanoma?</title>
            <link>http://www.medworm.com/index.php?rid=5384539&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F14g86g32l290v088%2F</link>
            <description>Content Type Journal ArticleCategory ErratumPages 1-2DOI 10.1245/s10434-011-2131-3Authors
		Jonathan S. Zager, Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USAChristopher A. Puleo, Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USAVernon K. Sondak, Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA
	

	
		Journal Annals of Surgical OncologyOnline ISSN 1534-4681Print ISSN 1068-9265 (Source: Annals of Surgical Oncology)</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5384539</comments>
            <pubDate>Thu, 03 Nov 2011 05:54:40 +0100</pubDate>
            <guid isPermaLink="false">5384539</guid>        </item>
        <item>
            <title>A Pathway-Based Approach to Identify Molecular Biomarkers in Cancer</title>
            <link>http://www.medworm.com/index.php?rid=5384538&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F9733w865v1133124%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Many examples highlight the power of gene expression profiles, or signatures, to provide an understanding of biological phenotypes.
 This is best seen in the context of cancer, where expression signatures have tremendous power to identify new cancer subtypes
 and to predict clinical outcomes. Gene expression profiles have been developed to personalize medicine, accurately predicting
 disease recurrence and tumor response to therapy. The use of these signatures as surrogate phenotypes allows us to link diverse
 experimental systems, which dissect the complexity of biological systems, with the in vivo setting in a way that was not previously
 feasible. Taken together, these new genomic tools provide the opportunity to develop rational strategies for treating the
 individu...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5384538</comments>
            <pubDate>Thu, 03 Nov 2011 05:54:40 +0100</pubDate>
            <guid isPermaLink="false">5384538</guid>        </item>
        <item>
            <title>The Combined Expression of Metaplasia Biomarkers Predicts the Prognosis Of Gastric Cancer</title>
            <link>http://www.medworm.com/index.php?rid=5384541&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn618644612j7q625%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The combined loss of expression of multiple metaplasia biomarkers is considered an independent prognostic indicator in undifferentiated
 or stage II/III gastric cancer.
 
 
 
 
	Content Type Journal ArticleCategory Gastrointestinal OncologyPages 1-10DOI 10.1245/s10434-011-2125-1Authors
		Yun-Suhk Suh, Department of Surgery, Seoul National University College of Medicine, Seoul, KoreaHyuk-Joon Lee, Department of Surgery, Seoul National University College of Medicine, Seoul, KoreaEun-Jung Jung, Department of Pathology, Seoul National University, Seoul, KoreaMin-A Kim, Department of Pathology, Seoul National University, Seoul, KoreaKi Taek Nam, Nashville VA Medical Center and the Epithelial Biology Center and Section of Surgical Sciences, Vanderbilt University, Nashville...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5384541</comments>
            <pubDate>Wed, 02 Nov 2011 16:57:51 +0100</pubDate>
            <guid isPermaLink="false">5384541</guid>        </item>
        <item>
            <title>What is the Best Criterion for the Interpretation of Adrenal Vein Sample Results in Patients with Primary Hyperaldosteronism?</title>
            <link>http://www.medworm.com/index.php?rid=5384540&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx452m3724142vw14%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Of the multiple criteria used for AVS evaluation, one criterion has the best accuracy. With the increasing use of AVS, there
 should be a consensus by which these results are evaluated and surgeons recommend adrenalectomy.
 
 
 
 
	Content Type Journal ArticleCategory Endocrine TumorsPages 1-6DOI 10.1245/s10434-011-2121-5Authors
		Richard Webb, Endocrine Oncology Section, Surgery Branch, National Cancer Institute, Bethesda, MD, USAAarti Mathur, Endocrine Oncology Section, Surgery Branch, National Cancer Institute, Bethesda, MD, USARichard Chang, Department of Diagnostic Radiology, Warren F Magnuson Clinical Center, Bethesda, MD, USASmita Baid, Program in Developmental Endocrinology and Genetics, Eunice Kennedy Shriver National Institutes of Child Health and Human Dev...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5384540</comments>
            <pubDate>Wed, 02 Nov 2011 16:57:51 +0100</pubDate>
            <guid isPermaLink="false">5384540</guid>        </item>
        <item>
            <title>Diagnostic Value of Sentinel Lymph Node Biopsy in Gastric Cancer: A Meta-Analysis</title>
            <link>http://www.medworm.com/index.php?rid=5384542&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm33n2031l7pqh317%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;SLNB in GC is technically feasible with an acceptable sensitivity. However, further studies are needed to confirm the best
 procedure and standard criteria.
 
 
 
 
	Content Type Journal ArticleCategory Gastrointestinal OncologyPages 1-10DOI 10.1245/s10434-011-2124-2Authors
		Zhen Wang, Department of Gastrointestinal Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, ChinaZhi-Yong Dong, Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, ChinaJun-Qiang Chen, Department of Gastrointestinal Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, ChinaJin-Lu Liu, Department of Gastrointestinal Surgery, The First Affiliated Hospital of Guangxi Medical University, Nan...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5384542</comments>
            <pubDate>Wed, 02 Nov 2011 16:57:50 +0100</pubDate>
            <guid isPermaLink="false">5384542</guid>        </item>
        <item>
            <title>The Value of Palliative Gastrectomy in Gastric Cancer with Distant Metastasis</title>
            <link>http://www.medworm.com/index.php?rid=5384543&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff26076t471115257%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;This retrospective study suggests that surgical resection in metastatic gastric cancer may improve survival when combined
 with chemotherapy, especially when metastasis is confined to one site.
 
 
 
 
	Content Type Journal ArticleCategory Gastrointestinal OncologyPages 1-9DOI 10.1245/s10434-011-2056-xAuthors
		Ye Rim Chang, Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, KoreaDong Seok Han, Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, KoreaSeong-Ho Kong, Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, KoreaHyuk-Joon Lee, Department of Surgery and Cancer Research Institute, Seoul National U...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5384543</comments>
            <pubDate>Wed, 02 Nov 2011 05:48:20 +0100</pubDate>
            <guid isPermaLink="false">5384543</guid>        </item>
        <item>
            <title>Feasibility of Robot-Assisted Neck Dissections via a Transaxillary and Retroauricular (“TARA”) Approach in Head and Neck Cancer: Preliminary Results</title>
            <link>http://www.medworm.com/index.php?rid=5384544&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F648v7w3254j3n740%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Robotic neck dissection via TARA approach is a feasible and useful method with excellent cosmetic results for treating nodal
 metastasis in selected cases of head and neck squamous cell cancer.
 
 
 
 
	Content Type Journal ArticleCategory Head and Neck OncologyPages 1-9DOI 10.1245/s10434-011-2116-2Authors
		Won Shik Kim, Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, KoreaHyoung Shin Lee, Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, KoreaSung Mi Kang, Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, KoreaHyun Jun Hong, Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, KoreaYoon Woo Koh, Department of Otorhinolaryngology, Yonsei Univers...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5384544</comments>
            <pubDate>Wed, 02 Nov 2011 05:48:19 +0100</pubDate>
            <guid isPermaLink="false">5384544</guid>        </item>
        <item>
            <title>Risk Factors for Bronchopleural Fistula After Right Pneumonectomy: Does Eliminating the Stump Diverticulum Provide Protection?</title>
            <link>http://www.medworm.com/index.php?rid=5384545&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm8g07644uuk22516%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;In our experience, higher preoperative radiation doses are a risk factor for BPF after right pneumonectomy, while carinal
 closure exerts a protective effect.
 
 
 
 
	Content Type Journal ArticleCategory Thoracic OncologyPages 1-7DOI 10.1245/s10434-011-2119-zAuthors
		Thomas J. Birdas, Cardiothoracic Division, Department of Surgery, Indiana University Melvin and Bren Simon Cancer Center, Indiana University School of Medicine, Indianapolis, USAMohamed H. Morad, Cardiothoracic Division, Department of Surgery, Indiana University Melvin and Bren Simon Cancer Center, Indiana University School of Medicine, Indianapolis, USAIkenna C. Okereke, Cardiothoracic Division, Department of Surgery, Indiana University Melvin and Bren Simon Cancer Center, Indiana University School of...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5384545</comments>
            <pubDate>Wed, 02 Nov 2011 05:48:18 +0100</pubDate>
            <guid isPermaLink="false">5384545</guid>        </item>
        <item>
            <title>Carcinoma of the Ampulla of Vater: Patterns of Failure Following Resection and Benefit of Chemoradiotherapy</title>
            <link>http://www.medworm.com/index.php?rid=5384547&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F32582j278h751713%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Long-term survival rates are low and local failure rates high following radical resection alone. Given patterns of relapse
 with surgery alone and local control benefit in patients receiving CRT, the use of chemoradiotherapy in selected patients
 should be considered.
 
 
 
 
	Content Type Journal ArticleCategory Gastrointestinal OncologyPages 1-6DOI 10.1245/s10434-011-2117-1Authors
		Manisha Palta, Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USAPretesh Patel, Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USAGloria Broadwater, Cancer Statistical Center, Duke University Medical Center, Durham, NC, USAChristopher Willett, Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USAJo...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5384547</comments>
            <pubDate>Tue, 01 Nov 2011 16:52:48 +0100</pubDate>
            <guid isPermaLink="false">5384547</guid>        </item>
        <item>
            <title>Pathologic Nonresponders after Neoadjuvant Chemoradiation for Esophageal Cancer Demonstrate no Survival Benefit Compared with Patients Treated with Primary Esophagectomy</title>
            <link>http://www.medworm.com/index.php?rid=5384546&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fur90504785763226%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Pathologic nonresponders to NCRT for esophageal cancer receive no benefit in DFS or OS compared with patients treated with
 PE. For patients with stage II disease, DFS and OS are, in fact, significantly decreased in the pNR.
 
 
 
 
	Content Type Journal ArticleCategory Thoracic OncologyPages 1-7DOI 10.1245/s10434-011-2078-4Authors
		George W. Dittrick, Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, USAJill M Weber, Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, USARavi Shridhar, Department of Radiation Oncology, Moffitt Cancer Center, Tampa, FL, USASarah Hoffe, Department of Radiation Oncology, Moffitt Cancer Center, Tampa, FL, USAMarcovalerio Melis, Department of Surgery, New York Presbyterian Veterans Adminis...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5384546</comments>
            <pubDate>Tue, 01 Nov 2011 16:52:48 +0100</pubDate>
            <guid isPermaLink="false">5384546</guid>        </item>
        <item>
            <title>Erratum to: Incomplete Sentinel Node Biopsy Is Not Clearly Related to Survival or Regional Recurrence in Cutaneous Melanoma Patients</title>
            <link>http://www.medworm.com/index.php?rid=5384548&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft23t28113688q4t3%2F</link>
            <description>Content Type Journal ArticleCategory ErratumPages 1-2DOI 10.1245/s10434-011-2118-0Authors
		Nicholas C. Lee, Royal North Shore Hospital, St. Leonards, AustraliaAndrew J. Spillane, Royal North Shore Hospital, St. Leonards, AustraliaTony C. Y. Pang, Royal North Shore Hospital, St. Leonards, AustraliaLauren E. Haydu, Sydney Medical School, The University of Sydney, Sydney, AustraliaRoger F. Uren, Sydney Medical School, The University of Sydney, Sydney, Australia
	

	
		Journal Annals of Surgical OncologyOnline ISSN 1534-4681Print ISSN 1068-9265 (Source: Annals of Surgical Oncology)</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5384548</comments>
            <pubDate>Sat, 29 Oct 2011 05:49:04 +0100</pubDate>
            <guid isPermaLink="false">5384548</guid>        </item>
        <item>
            <title>Poorer Prognosis and Higher Prevalence of BRAFV600E Mutation in Synchronous Bilateral Papillary Thyroid Carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5359945&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4377103w05qv4456%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Patients with SBiPTC present with more advanced tumor stage and have shorter disease-free survival than UiPTC patients. Poorer
 outcomes of these patients may be at least partially explained by the high incidence of BRAF
 V600E mutation.
 
 
 
 
	Content Type Journal ArticleCategory Endocrine TumorsPages 1-6DOI 10.1245/s10434-011-2096-2Authors
		Weibin Wang, Cancer Center, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaWenhe Zhao, Cancer Center, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaHaiyong Wang, Cancer Center, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaXiaodong Teng, Department of Pathology, First Affiliated Hospital, Zhejiang University School of Me...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5359945</comments>
            <pubDate>Thu, 27 Oct 2011 15:46:01 +0100</pubDate>
            <guid isPermaLink="false">5359945</guid>        </item>
        <item>
            <title>Hormone Treatment without Surgery for Patients Aged 75 Years or Older with Operable Breast Cancer</title>
            <link>http://www.medworm.com/index.php?rid=5359946&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff1w1r116x54n755w%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Tumor progression was observed in a substantial proportion of the cohort, but only a small number of patients died of breast
 cancer. Further research is needed on the safety and effectiveness of PET for elderly women with breast cancer to justify
 the current widespread use.
 
 
 
 
	Content Type Journal ArticleCategory Breast OncologyPages 1-7DOI 10.1245/s10434-011-2070-zAuthors
		C. J. Wink, Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The NetherlandsK. Woensdregt, Department of Surgery, Maastricht University Medical Center, Maastricht, The NetherlandsG. A. P. Nieuwenhuijzen, Department of Surgery, Catharina Hospital, Eindhoven, The NetherlandsM. J. C. van der Sangen, Department of Radiotherapy, Catharina Hospital, Eindhoven, Th...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5359946</comments>
            <pubDate>Thu, 27 Oct 2011 05:36:34 +0100</pubDate>
            <guid isPermaLink="false">5359946</guid>        </item>
        <item>
            <title>Impact of Race/Ethnicity on Prognosis in Patients Who Underwent Surgery for Colon Cancer: Analysis for White, African, and East Asian Americans</title>
            <link>http://www.medworm.com/index.php?rid=5346882&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2717315178446267%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;East Asian American patients had significantly better prognosis, while African American patients had worse prognosis than
 non-Hispanic white patients, despite the identical adjusted number of lymph nodes examined after surgery for colon cancer.
 This disparity in prognosis among races/ethnicities should be taken into consideration when deciding adjuvant chemotherapy
 for nonwhite patients.
 
 
 
 
	Content Type Journal ArticleCategory Colorectal CancerPages 1-12DOI 10.1245/s10434-011-2113-5Authors
		Yojiro Hashiguchi, Department of Surgery, National Defense Medical College, Saitama, JapanKazuo Hase, Department of Surgery, National Defense Medical College, Saitama, JapanHideki Ueno, Department of Surgery, National Defense Medical College, Saitama, JapanEiji Shinto, D...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5346882</comments>
            <pubDate>Thu, 20 Oct 2011 05:55:45 +0100</pubDate>
            <guid isPermaLink="false">5346882</guid>        </item>
        <item>
            <title>Neoadjuvant/Preoperative Gemcitabine for Patients with Localized Pancreatic Cancer: A Meta-analysis of Prospective Studies</title>
            <link>http://www.medworm.com/index.php?rid=5346883&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq51q24q5l2047404%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Current analysis provides marginal support to the assumed benefits of neoadjuvant therapies for patients with resectable cancer,
 and indicates a potential advantage only for a minority of those with unresectable lesions.
 
 
 
 
	Content Type Journal ArticleCategory Pancreatic TumorsPages 1-19DOI 10.1245/s10434-011-2110-8Authors
		Angelo Andriulli, Division of Gastroenterology, “Casa Sollievo della Sofferenza” Hospital, IRCCS, San Giovanni Rotondo, ItalyVirginia Festa, Division of Gastroenterology, “San Filippo Neri” Hospital, Rome, ItalyEdoardo Botteri, Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, ItalyMaria R. Valvano, Division of Gastroenterology, “Casa Sollievo della Sofferenza” Hospital, IRCCS, San Giovanni Roto...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5346883</comments>
            <pubDate>Thu, 20 Oct 2011 05:55:44 +0100</pubDate>
            <guid isPermaLink="false">5346883</guid>        </item>
        <item>
            <title>The Predictive Effect of Cadherin-17 on Lymph Node Micrometastasis in pN0 Gastric Cancer</title>
            <link>http://www.medworm.com/index.php?rid=5335126&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk093n631797470t4%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;CDH17 was positively associated with larger tumor size, deeper invasion, diffuse/mixed histotype, LVI, and LNMM, predicting
 a poor prognosis in pN0 gastric cancer. Additionally, CDH17 may also serve as a potential indicator of LNMM.
 
 
 
 
	Content Type Journal ArticleCategory Gastrointestinal OncologyPages 1-6DOI 10.1245/s10434-011-2115-3Authors
		Jin Wang, Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaJian-Chun Yu, Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaWei-Ming Kang, Department of General Surgery, Peking Union Medical College Hospital, Chinese...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5335126</comments>
            <pubDate>Wed, 19 Oct 2011 05:57:11 +0100</pubDate>
            <guid isPermaLink="false">5335126</guid>        </item>
        <item>
            <title>Multifocality in Early Gastric Cancer Does not Increase the Risk of Lymph Node Metastasis in a Single-Center Study</title>
            <link>http://www.medworm.com/index.php?rid=5335127&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff7412um55571l286%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Synchronous multifocality of EGC does not increase the risk of lymph node metastasis compared with solitary EGC. Therefore,
 endoscopic treatment can be planned when major and minor lesions are predicted to represent mucosal cancer without lymphovascular
 invasion.
 
 
 
 
	Content Type Journal ArticleCategory Gastrointestinal OncologyPages 1-6DOI 10.1245/s10434-011-2083-7Authors
		Hee Man Kim, Department of Internal Medicine, Graduate School, Yonsei University College of Medicine, Seoul, Republic of KoreaHyun Ki Kim, Department of Pathology, Yonsei University College of Medicine, Seoul, Republic of KoreaSang Kil Lee, Division of Gastroenterology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of KoreaJae Hee Cho, Department o...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5335127</comments>
            <pubDate>Tue, 18 Oct 2011 05:47:28 +0100</pubDate>
            <guid isPermaLink="false">5335127</guid>        </item>
        <item>
            <title>Phyllodes Tumor of the Breast: Role of CD10 in Predicting Metastasis</title>
            <link>http://www.medworm.com/index.php?rid=5335130&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn0w20764132g8k1q%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The expression of CD10 can be used to predict the occurrence of distant metastasis in phyllodes tumors of the breast.
 
 
 
	Content Type Journal ArticleCategory Breast OncologyPages 1-4DOI 10.1245/s10434-011-2076-6Authors
		Mahmoud Al-Masri, Department of Surgical Oncology, King Hussein Cancer Center, Amman, JordanGhaleb Darwazeh, Department of Surgical Oncology, King Hussein Cancer Center, Amman, JordanSamer Sawalhi, Department of Surgical Oncology, King Hussein Cancer Center, Amman, JordanAyman Mughrabi, Department of Surgical Oncology, King Hussein Cancer Center, Amman, JordanMaher Sughayer, Department of Pathology, King Hussein Cancer Center, Amman, JordanMarwa Al-Shatti, Department of Pathology, King Hussein Cancer Center, Amman, Jordan
	

	
		Journal Annals of...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5335130</comments>
            <pubDate>Tue, 18 Oct 2011 05:47:27 +0100</pubDate>
            <guid isPermaLink="false">5335130</guid>        </item>
        <item>
            <title>Predictors of Nipple–Areolar Complex Involvement by Breast Carcinoma: Histopathologic Analysis of 787 Consecutive Therapeutic Mastectomy Specimens</title>
            <link>http://www.medworm.com/index.php?rid=5335129&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx5n03191w2027165%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;On the basis of our findings, we have developed a mathematical model that is based on the extent and location of the tumor,
 HER2 expression, and nuclear grade that predicts the probability of NAC involvement by breast cancer. This model may aid in
 preoperative planning in selecting appropriate surgical procedures based on an individual patient’s relative risk of NAC involvement.
 
 
 
 
	Content Type Journal ArticleCategory Breast OncologyPages 1-7DOI 10.1245/s10434-011-2107-3Authors
		Jianli Wang, Department of Pathophysiology, Shandong University School of Medicine, Shandong, ChinaXiuli Xiao, Department of Pathology, Luzhou Medical College, Luzhou, ChinaJianmin Wang, RTI Health Solution, Research Triangle Park, NC, USANaazneen Iqbal, Departments of Pathology, U...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5335129</comments>
            <pubDate>Tue, 18 Oct 2011 05:47:27 +0100</pubDate>
            <guid isPermaLink="false">5335129</guid>        </item>
        <item>
            <title>Expression Analysis Elucidates the Roles of MAML1 and Twist1 in Esophageal Squamous Cell Carcinoma Aggressiveness and Metastasis</title>
            <link>http://www.medworm.com/index.php?rid=5335128&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7vq4560n4j330218%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;We introduce Twist1 and MAML1 as new molecular markers of advanced tumor, which determine the characteristics and aggressive
 behavior of ESCC. Along with the emerging evidence of their role in different cellular processes and aberrations in various
 cancers, they are suggested as potentially interesting therapeutic targets to reverse a broad spectrum of functional aberrations
 that promote ESCC development.
 
 
 
 
	Content Type Journal ArticleCategory Thoracic OncologyPages 1-7DOI 10.1245/s10434-011-2074-8Authors
		Mohammad Mahdi Forghanifard, Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, IranOmeed Moaven, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USAMoein Farshchian, Human Gene...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5335128</comments>
            <pubDate>Tue, 18 Oct 2011 05:47:27 +0100</pubDate>
            <guid isPermaLink="false">5335128</guid>        </item>
        <item>
            <title>Outcome of Microscopic Incomplete Resection (R1) of Colorectal Liver Metastases in the Era of Neoadjuvant Chemotherapy</title>
            <link>http://www.medworm.com/index.php?rid=5335131&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv8067053w3422055%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;In patients treated with neoadjuvant chemotherapy, R1 resection was of no predictive value for DFS and OS.
 
 
 
	Content Type Journal ArticleCategory Hepatobiliary TumorsPages 1-10DOI 10.1245/s10434-011-2114-4Authors
		Ninos Ayez, Division of Surgical Oncology, Erasmus MC, Daniel den Hoed Cancer Center, Rotterdam, The NetherlandsZarina S. Lalmahomed, Division of Transplantation and Hepatobiliary Surgery, Erasmus MC, Rotterdam, The NetherlandsAlexander M. M. Eggermont, Institut de cancérologie Gustav Roussy, Villejuif, FranceJan N. M. Ijzermans, Division of Transplantation and Hepatobiliary Surgery, Erasmus MC, Rotterdam, The NetherlandsJeroen de Jonge, Division of Surgical Oncology, Erasmus MC, Daniel den Hoed Cancer Center, Rotterdam, The NetherlandsKees van Montf...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5335131</comments>
            <pubDate>Tue, 18 Oct 2011 05:47:26 +0100</pubDate>
            <guid isPermaLink="false">5335131</guid>        </item>
        <item>
            <title>Adjuvant Radiotherapy in the Treatment of Invasive Intraductal Papillary Mucinous Neoplasm of the Pancreas: an Analysis of the Surveillance, Epidemiology, and End Results Registry</title>
            <link>http://www.medworm.com/index.php?rid=5323646&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg485450371823l38%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;On propensity-score-adjusted analysis, adjuvant RT was associated with improved survival in selected subsets of patients with
 invasive IPMN, particularly those with T3/T4 tumors and LN involvement.
 
 
 
 
	Content Type Journal ArticleCategory Pancreatic TumorsPages 1-8DOI 10.1245/s10434-011-2088-2Authors
		Mathias Worni, Research on Research, Department of Surgery, Duke University Medical Center, Durham, NC, USAIgor Akushevich, Center for Population Health and Aging, Duke University, Durham, NC, USABeat Gloor, Department of Visceral Surgery and Medicine, University of Bern, Bern, SwitzerlandJohn Scarborough, Department of Surgery, Duke University Medical Center, Durham, NC, USAJunzo P. Chino, Department of Radiation Oncology, Duke University Medical Center, Durham, ...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5323646</comments>
            <pubDate>Fri, 14 Oct 2011 10:48:22 +0100</pubDate>
            <guid isPermaLink="false">5323646</guid>        </item>
        <item>
            <title>Association between Recency of Last Pregnancy and Biologic Subtype of Breast Cancer</title>
            <link>http://www.medworm.com/index.php?rid=5323648&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa7xh537w30142128%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;BC diagnosed within 2&amp;nbsp;years of pregnancy is more likely to have poor prognostic features and to be triple negative. More work
 is needed to delineate the time frame of pregnancy-associated BC and to define them on a molecular level, so as to devise
 better prevention and therapy for this devastating problem.
 
 
 
 
	Content Type Journal ArticleCategory Breast OncologyPages 1-7DOI 10.1245/s10434-011-2104-6Authors
		Melissa Pilewskie, Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL, USAPolina Gorodinsky, Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL, USAAngela Fought, Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USANora Hans...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5323648</comments>
            <pubDate>Fri, 14 Oct 2011 06:08:41 +0100</pubDate>
            <guid isPermaLink="false">5323648</guid>        </item>
        <item>
            <title>Right Trisectionectomy with Principle En Bloc Portal Vein Resection for Right-Sided Hilar Cholangiocarcinoma: No-Touch Technique</title>
            <link>http://www.medworm.com/index.php?rid=5323647&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj568738q522676k7%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Right trisectionectomy with en bloc portal vein and bile duct resection is feasible and may enhance chance for R0 resection
 and a better late outcome, especially in cases when portal vein is microscopically involved. Although described in 1999, there
 are few detailed descriptions of this procedure, and to the best of our knowledge, no multimedia articles are available. This
 video may help oncological surgeons to perform and standardize this challenging procedure.
 
 
 
 
	Content Type Journal ArticleCategory Original Article – Hepatobiliary TumorsPages 1-2DOI 10.1245/s10434-011-2072-xAuthors
		Marcel Autran Machado, Department of Gastroenterology, Surgical Division, University of Sao Paulo, São Paulo, BrazilFabio F. Makdissi, Department of Gastroenterology, Sur...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5323647</comments>
            <pubDate>Fri, 14 Oct 2011 06:08:41 +0100</pubDate>
            <guid isPermaLink="false">5323647</guid>        </item>
        <item>
            <title>Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Stage IV Ovarian Cancer</title>
            <link>http://www.medworm.com/index.php?rid=5323649&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa60212328v321574%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;NACT-IDS for stage IV ovarian cancer resulted in higher rates of complete resection to no residual disease, less morbidity,
 and equivalent OS compared to PDS.
 
 
 
 
	Content Type Journal ArticleCategory Gynecologic OncologyPages 1-7DOI 10.1245/s10434-011-2100-xAuthors
		J. Alejandro Rauh-Hain, Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USANoah Rodriguez, Division of Gynecologic Oncology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USAWhitfield B. Growdon, Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USAA. K. Goodman, Division of Gynecologic Oncology, Vincent...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5323649</comments>
            <pubDate>Thu, 13 Oct 2011 05:48:55 +0100</pubDate>
            <guid isPermaLink="false">5323649</guid>        </item>
        <item>
            <title>Biliary Sclerosis after Hepatic Arterial Infusion Pump Chemotherapy for Patients with Colorectal Cancer Liver Metastasis: Incidence, Clinical Features, and Risk Factors</title>
            <link>http://www.medworm.com/index.php?rid=5313861&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy1v477n567np8605%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;BS is an uncommon complication after HAIPC and does not compromise survival if adequately salvaged by stenting or dilatation.
 Surgical complications as well as type and dose of intra-arterial chemotherapy may contribute to the development of BS.
 
 
 
 
	Content Type Journal ArticleCategory Hepatobiliary TumorsPages 1-9DOI 10.1245/s10434-011-2102-8Authors
		Kaori Ito, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USAHiromichi Ito, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USANancy E. Kemeny, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USAMithat Gonen, Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USAPeter J. Allen,...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5313861</comments>
            <pubDate>Wed, 12 Oct 2011 05:46:15 +0100</pubDate>
            <guid isPermaLink="false">5313861</guid>        </item>
        <item>
            <title>Cortical and Subventricular Zone Glioblastoma-Derived Stem-Like Cells Display Different Molecular Profiles and Differential In Vitro and In Vivo Properties</title>
            <link>http://www.medworm.com/index.php?rid=5313860&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg4881797448732r8%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Altogether, our findings suggest that tumor location in addition to molecular signature influence tumor growth and migration
 pattern.
 
 
 
 
	Content Type Journal ArticleCategory Translational Research and BiomarkersPages 1-12DOI 10.1245/s10434-011-2093-5Authors
		Aurélie Tchoghandjian, Inserm U911, Marseille, FranceNathalie Baeza-Kallee, Inserm U911, Marseille, FranceChristophe Beclin, CNRS, Marseille, FrancePhilippe Metellus, Inserm U911, Marseille, FranceCarole Colin, Inserm U911, Marseille, FranceFrançois Ducray, Inserm, U842, Lyon, FranceJosé Adélaïde, Inserm, U599, Marseille, FranceGeneviève Rougon, CNRS, Marseille, FranceDominique Figarella-Branger, Inserm U911, Marseille, France
	

	
		Journal Annals of Surgical OncologyOnline ISSN 1534-4681Print ISSN...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5313860</comments>
            <pubDate>Wed, 12 Oct 2011 05:46:15 +0100</pubDate>
            <guid isPermaLink="false">5313860</guid>        </item>
        <item>
            <title>Local Recurrence after Breast-Conserving Surgery: Multivariable Analysis of Risk Factors and the Impact of Young Age</title>
            <link>http://www.medworm.com/index.php?rid=5313863&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff8u60741311482x0%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Risk factors for LR after BCS include age &amp;lt;40&amp;nbsp;years, node positivity, ER negativity, and absence of adjuvant radiation therapy.
 Patients younger than age 40&amp;nbsp;years are at increased risk of LR after BCS.
 
 
 
 
	Content Type Journal ArticleCategory Breast OncologyPages 1-7DOI 10.1245/s10434-011-2084-6Authors
		Randy C. Miles, Mayo Medical School, Mayo Clinic, Rochester, MN, USARachel E. Gullerud, Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USAChristine M. Lohse, Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USAJames W. Jakub, Department of Surgery, Mayo Clinic, Rochester, MN, USAAmy C. Degnim, Department of Surgery, Mayo Clinic, Rochester, MN, USAJudy C. Boughey, Department of Surgery, Mayo Clinic, Rochester, M...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5313863</comments>
            <pubDate>Wed, 12 Oct 2011 05:46:14 +0100</pubDate>
            <guid isPermaLink="false">5313863</guid>        </item>
        <item>
            <title>Clinical Implications of Occult Metastases and Isolated Tumor Cells in Sentinel and Non-Sentinel Lymph Nodes in Early Breast Cancer Patients: Serial Step Section Analysis with Long-Term Follow-Up</title>
            <link>http://www.medworm.com/index.php?rid=5313862&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp041278v178h7827%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;SLN or non-SLN occult metastases detected by serial step sections at 85-μm intervals did not have significant prognostic implications.
 
 
 
	Content Type Journal ArticleCategory Breast OncologyPages 1-7DOI 10.1245/s10434-011-2085-5Authors
		Takashi Takeshita, Department of Surgery, National Defense Medical College, Tokorozawa, Saitama, JapanHitoshi Tsuda, Department of Basic Pathology, National Defense Medical College, Tokorozawa, Saitama, JapanTomoyuki Moriya, Department of Surgery, National Defense Medical College, Tokorozawa, Saitama, JapanTamio Yamasaki, Department of Surgery, National Defense Medical College, Tokorozawa, Saitama, JapanHideki Asakawa, Department of Surgery, National Defense Medical College, Tokorozawa, Saitama, JapanShigeto Ueda, Department of ...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5313862</comments>
            <pubDate>Wed, 12 Oct 2011 05:46:14 +0100</pubDate>
            <guid isPermaLink="false">5313862</guid>        </item>
        <item>
            <title>The Impact of Primary Melanoma Thickness and Microscopic Tumor Burden in Sentinel Lymph Nodes on Melanoma Patient Survival</title>
            <link>http://www.medworm.com/index.php?rid=5313864&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx063l5glj3870322%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;PMT and MMS were independently prognostic of PFS and OS in melanoma patients. Patients with negative CLND had significantly
 better PFS and OS than those with positive CLND.
 
 
 
 
	Content Type Journal ArticleCategory MelanomasPages 1-9DOI 10.1245/s10434-011-2095-3Authors
		Frederick L. Baehner, Department of Pathology, University of California, San Francisco and UCSF Comprehensive Cancer Center, San Francisco, CA, USARui Li, Division of Biostatistics, Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USATyler Jenkins, Department of Surgery, University of California, San Francisco and UCSF Comprehensive Cancer Center, San Francisco, CA, USAJimmy Hwang, Department of Biostatistics, University of California, San Francisco and UCSF...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5313864</comments>
            <pubDate>Wed, 12 Oct 2011 05:46:11 +0100</pubDate>
            <guid isPermaLink="false">5313864</guid>        </item>
        <item>
            <title>High Lymph Node Yield is Related to Microsatellite Instability in Colon Cancer</title>
            <link>http://www.medworm.com/index.php?rid=5313866&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm4v763j1140746u0%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;In the present study, high LN yield was associated with MSI tumors, mainly in stage III patients. Besides adequate surgery
 and pathology, high LN yield is possibly a feature caused by biologic behavior of MSI tumors.
 
 
 
 
	Content Type Journal ArticleCategory Colorectal CancerPages 1-9DOI 10.1245/s10434-011-2091-7Authors
		E. J. Th. Belt, Department of Surgery, VU University Medical Centre, Amsterdam, The NetherlandsE. A. te Velde, Department of Surgery, VU University Medical Centre, Amsterdam, The NetherlandsO. Krijgsman, Department of Pathology, VU University Medical Centre, Amsterdam, The NetherlandsR. P. M. Brosens, Department of Surgery, VU University Medical Centre, Amsterdam, The NetherlandsM. Tijssen, Department of Pathology, VU University Medical Centre,...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5313866</comments>
            <pubDate>Wed, 12 Oct 2011 05:46:10 +0100</pubDate>
            <guid isPermaLink="false">5313866</guid>        </item>
        <item>
            <title>Is Focused Minimally Invasive Parathyroidectomy Appropriate for Patients With Familial Primary Hyperparathyroidism?</title>
            <link>http://www.medworm.com/index.php?rid=5313865&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F61722g8x47452005%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;The vast majority of patients who underwent a MIP were surgically cured. Although recurrence rates remain higher in the familial
 hyperparathyroidism group, these data suggest that this alone should not be a contraindication to MIP.
 
 
 
 
	Content Type Journal ArticleCategory Endocrine TumorsPages 1-5DOI 10.1245/s10434-011-2092-6Authors
		Ruth S. Prichard, University of Sydney Endocrine Surgical Unit, Sydney, AustraliaChristine J. O’Neill, University of Sydney Endocrine Surgical Unit, Sydney, AustraliaJennifer J. Oucharek, University of Sydney Endocrine Surgical Unit, Sydney, AustraliaRebecca S. Sippel, Department of Surgery, Section of Endocrine Surgery, University of Wisconsin, Madison, WI, USALeigh W. Delbridge, University of Sydney Endocrine Surgical Unit, Sy...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5313865</comments>
            <pubDate>Wed, 12 Oct 2011 05:46:10 +0100</pubDate>
            <guid isPermaLink="false">5313865</guid>        </item>
        <item>
            <title>Significance of Metastatic Lymph Node Ratio on Stimulated Thyroglobulin Levels in Papillary Thyroid Carcinoma after Prophylactic Unilateral Central Neck Dissection</title>
            <link>http://www.medworm.com/index.php?rid=5313870&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu76261565428510l%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;A higher CLNR was associated with a higher rate of postablative DsTg; this may imply higher future recurrence rate.
 
 
 
	Content Type Journal ArticleCategory Endocrine TumorsPages 1-7DOI 10.1245/s10434-011-2105-5Authors
		Brian Hung-Hin Lang, Department of Surgery, The University of Hong Kong, Hong Kong, Hong Kong SAR, ChinaKai Pun Wong, Department of Surgery, The University of Hong Kong, Hong Kong, Hong Kong SAR, ChinaKoon Yat Wan, Department of Clinical Oncology, The University of Hong Kong, Hong Kong, Hong Kong SAR, ChinaChung-Yau Lo, Department of Surgery, The University of Hong Kong, Hong Kong, Hong Kong SAR, China
	

	
		Journal Annals of Surgical OncologyOnline ISSN 1534-4681Print ISSN 1068-9265 (Source: Annals of Surgical Oncology)</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5313870</comments>
            <pubDate>Wed, 12 Oct 2011 05:46:09 +0100</pubDate>
            <guid isPermaLink="false">5313870</guid>        </item>
        <item>
            <title>Erratum to: Overexpression of Renal Tumor Antigen Is Associated with Tumor Invasion and Poor Prognosis of Hepatocellular Carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5313869&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F430130276816357n%2F</link>
            <description>Content Type Journal ArticleCategory ErratumPages 1-1DOI 10.1245/s10434-011-2111-7Authors
		Hyung Jin Cha, Department of Life Science, Pohang University of Science and Technology, Pohang, KoreaJongmin Kim, Cbs Bioscience Inc., Daejeon, KoreaSun Mi Hong, Department of Life Science, Pohang University of Science and Technology, Pohang, KoreaSeok Joo Hong, Cbs Bioscience Inc., Daejeon, KoreaJun Ho Park, Cbs Bioscience Inc., Daejeon, KoreaEung-Sam Kim, School of Interdisciplinary Bioscience and Bioengineering, Pohang University of Science and Technology, Pohang, KoreaHee-Jung Wang, Department of Surgery, Ajou University School of Medicine, Suwon, KoreaYoon Jung Choi, Department of Pathology, National Health Insurance Corporation Ilsan Hospital, Goyang, Gyeonggi, KoreaIn-Gu Do, Experimental Pa...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5313869</comments>
            <pubDate>Wed, 12 Oct 2011 05:46:09 +0100</pubDate>
            <guid isPermaLink="false">5313869</guid>        </item>
        <item>
            <title>Preoperative Chemotherapy for Localized Squamous Cell Carcinoma of the Esophagus? We Should Go Back to the Drawing Board!</title>
            <link>http://www.medworm.com/index.php?rid=5313868&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl46338l66738q708%2F</link>
            <description>Content Type Journal ArticleCategory Thoracic OncologyPages 1-2DOI 10.1245/s10434-011-2101-9Authors
		Jaffer A. Ajani, Department of GI Medical Oncology, UTMD Anderson Cancer Center, Houston, USAStephen G. Swisher, Department of Thoracic and Cardiovascular Surgery, UTMD Anderson Cancer Center, Houston, USA
	

	
		Journal Annals of Surgical OncologyOnline ISSN 1534-4681Print ISSN 1068-9265 (Source: Annals of Surgical Oncology)</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5313868</comments>
            <pubDate>Wed, 12 Oct 2011 05:46:09 +0100</pubDate>
            <guid isPermaLink="false">5313868</guid>        </item>
        <item>
            <title>Influence of Surgical Volume on Outcome for Laparoscopic Hysterectomy for Endometrial Cancer</title>
            <link>http://www.medworm.com/index.php?rid=5313867&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv5227225123vu262%2F</link>
            <description>Conclusion&amp;nbsp;&amp;nbsp;Laparoscopic hysterectomy for endometrial cancer is well tolerated and associated with an acceptable morbidity profile. Surgeon
 and hospital volume appear to have little effect on perioperative morbidity, mortality, and resource utilization.
 
 
 
 
	Content Type Journal ArticleCategory Gynecologic OncologyPages 1-11DOI 10.1245/s10434-011-2090-8Authors
		Jason D. Wright, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY, USADawn L. Hershman, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USAWilliam M. Burke, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and S...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5313867</comments>
            <pubDate>Wed, 12 Oct 2011 05:46:09 +0100</pubDate>
            <guid isPermaLink="false">5313867</guid>        </item>
        <item>
            <title>Clinical Efficacy of Sentinel Lymph Node Biopsy Using Methylene Blue Dye in Clinically Node-Negative Papillary Thyroid Carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5313871&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fbn834203153k3365%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;SLNB using methylene blue in papillary thyroid carcinoma is a safe and technically feasible procedure. However, it is of limited
 use in the management of clinically node-negative papillary thyroid carcinoma because of low sensitivity and a high false-negative
 rate.
 
 
 
 
	Content Type Journal ArticleCategory Endocrine TumorsPages 1-6DOI 10.1245/s10434-011-2109-1Authors
		Yong Bae Ji, Department of Otolaryngology—Head and Neck Surgery, College of Medicine, Hanyang University, Seoul, KoreaKeon Joong Lee, Department of Otolaryngology—Head and Neck Surgery, College of Medicine, Hanyang University, Seoul, KoreaYong Soo Park, Department of Endocrinology, College of Medicine, Hanyang University, Seoul, KoreaSang Mo Hong, Department of Endocrinology, College of Medic...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5313871</comments>
            <pubDate>Wed, 12 Oct 2011 05:46:05 +0100</pubDate>
            <guid isPermaLink="false">5313871</guid>        </item>
        <item>
            <title>Impact of FOXA1 Expression on the Prognosis of Patients with Hormone Receptor-Positive Breast Cancer</title>
            <link>http://www.medworm.com/index.php?rid=5304073&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu8q073601x9r064k%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;In HR-positive breast cancer, FOXA1 expression was significantly associated with good prognosis. FOXA1 expression may be a
 useful marker for HR-positive/HER2-negative breast cancer to identify patients with good prognosis who may not require CT.
 
 
 
 
	Content Type Journal ArticleCategory Breast OncologyPages 1-8DOI 10.1245/s10434-011-2094-4Authors
		Yuichi Hisamatsu, Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, JapanEriko Tokunaga, Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, JapanNami Yamashita, Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, JapanSayuri Akiyoshi, Department of Surgery and Science, Grad...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5304073</comments>
            <pubDate>Fri, 07 Oct 2011 15:57:12 +0100</pubDate>
            <guid isPermaLink="false">5304073</guid>        </item>
        <item>
            <title>Tumor-Associated Antigen Expressing Listeria monocytogenes Induces Effective Primary and Memory T-Cell Responses Against Hepatic Colorectal Cancer Metastases</title>
            <link>http://www.medworm.com/index.php?rid=5304075&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F43703856141w3021%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;This L. monocytogenes strain generated a highly effective antitumor T-cell response, providing a basis for the development of this vaccine platform
 in patients with liver metastases.
 
 
 
 
	Content Type Journal ArticleCategory Translational Research and BiomarkersPages 1-11DOI 10.1245/s10434-011-2037-0Authors
		Kelly Olino, Department of Surgery, Sidney Kimmel Cancer Center, Johns Hopkins Medical Institutions, Baltimore, MD, USASatoshi Wada, Immunology and Hematopoiesis Division, Department of Medical Oncology, Sidney Kimmel Cancer Center, Johns Hopkins Medical Institutions, Baltimore, MD, USABarish H. Edil, Department of Surgery, Sidney Kimmel Cancer Center, Johns Hopkins Medical Institutions, Baltimore, MD, USAXiaoyu Pan, Immunology and Hematopoiesis Division, D...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5304075</comments>
            <pubDate>Fri, 07 Oct 2011 05:45:15 +0100</pubDate>
            <guid isPermaLink="false">5304075</guid>        </item>
        <item>
            <title>Prospective Evaluation of the Nipple–Areola Complex Sparing Mastectomy for Risk Reduction and for Early-Stage Breast Cancer</title>
            <link>http://www.medworm.com/index.php?rid=5304074&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl347835316kn6x54%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;NSM is technically feasible in select patients, with a low risk for NAC removal resulting from necrosis or intraoperative
 detection of cancer, and preserves sensation and QOL. Thorough pathologic assessment of the NAC base is critical to ensure
 disease eradication.
 
 
 
 
	Content Type Journal ArticleCategory Breast OncologyPages 1-8DOI 10.1245/s10434-011-2099-zAuthors
		Jamie L. Wagner, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USARegina Fearmonti, Department of Surgery, Duke University, Durham, USAKelly K. Hunt, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USARosa F. Hwang, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston,...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5304074</comments>
            <pubDate>Fri, 07 Oct 2011 05:45:15 +0100</pubDate>
            <guid isPermaLink="false">5304074</guid>        </item>
        <item>
            <title>A High Body Mass Index in Esophageal Cancer Patients Does Not Influence Postoperative Outcome or Long-Term Survival</title>
            <link>http://www.medworm.com/index.php?rid=5304076&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk3l82j4h15817m36%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;A high BMI is not associated with an increased incidence or severity of complications after esophagectomy; however, anastomotic
 leakage occurred more frequently in obese patients. Five-year survival rates were not influenced by the preoperative BMI.
 A high BMI is therefore ought not be an exclusion criterion for esophagectomy.
 
 
 
 
	Content Type Journal ArticleCategory Gastrointestinal OncologyPages 1-6DOI 10.1245/s10434-011-2103-7Authors
		R. L. G. M. Blom, Department of Surgery, Academic Medical Center, Amsterdam, The NetherlandsS. M. Lagarde, Department of Surgery, Academic Medical Center, Amsterdam, The NetherlandsJ. H. G. Klinkenbijl, Department of Surgery, Academic Medical Center, Amsterdam, The NetherlandsO. R. C. Busch, Department of Surgery, Academic Me...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5304076</comments>
            <pubDate>Fri, 07 Oct 2011 05:45:14 +0100</pubDate>
            <guid isPermaLink="false">5304076</guid>        </item>
        <item>
            <title>Precise Pathologic Examination Decreases the False-Negative Rate of Sentinel Lymph Node Biopsy in Gastric Cancer</title>
            <link>http://www.medworm.com/index.php?rid=5304077&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F321153r45u56g352%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Our study indicated that precise and detailed intraoperative examination decreases the false-negative rate of SLN biopsy.
 ITCs in SLNs should not be overlooked, and rapid IHC can be helpful for detecting ITCs intraoperatively.
 
 
 
 
	Content Type Journal ArticleCategory Gastrointestinal OncologyPages 1-7DOI 10.1245/s10434-011-2106-4Authors
		Hye Seung Lee, Department of Pathology, Seoul National University Bundang Hospital, Seongnam, KoreaHee Eun Lee, Department of Pathology, Seoul National University Hospital, Seoul, KoreaDo Joong Park, Department of Surgery, Seoul National University Bundang Hospital, Seongnam, KoreaYoung Soo Park, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, KoreaHyung-Ho Kim, Department of Surgery, Seo...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5304077</comments>
            <pubDate>Fri, 07 Oct 2011 05:45:13 +0100</pubDate>
            <guid isPermaLink="false">5304077</guid>        </item>
        <item>
            <title>Which Eligible Breast Conservation Patients Choose Mastectomy in the Setting of Newly Diagnosed Breast Cancer?</title>
            <link>http://www.medworm.com/index.php?rid=5304078&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu79q7r3553015271%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;One in four eligible BCT patients chooses mastectomy. Factors independently associated with choosing mastectomy over BCT include
 findings of second-site biopsy, previous mastectomy, and absence of comorbidities but not primary tumor characteristics. Further
 study into a patient’s choice for mastectomy is warranted.
 
 
 
 
	Content Type Journal ArticleCategory Breast OncologyPages 1-8DOI 10.1245/s10434-011-2080-xAuthors
		Cameron D. Adkisson, Department of General Surgery, Mayo Clinic Florida, Jacksonville, USASanjay P. Bagaria, Department of General Surgery, Mayo Clinic Florida, Jacksonville, USAAlexander S. Parker, Department of General Surgery, Mayo Clinic Florida, Jacksonville, USAJillian M. Bray, Department of General Surgery, Mayo Clinic Florida, Jacksonvil...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5304078</comments>
            <pubDate>Thu, 06 Oct 2011 06:29:19 +0100</pubDate>
            <guid isPermaLink="false">5304078</guid>        </item>
        <item>
            <title>TNFAIP8 Overexpression: Clinical Relevance to Esophageal Squamous Cell Carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5296586&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fvv6uw4t442637657%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Our results suggest that TNFAIP8 might be an effective therapeutic target for ESCC in the future.
 
 
 
 
	Content Type Journal ArticleCategory Translational Research and BiomarkersPages 1-8DOI 10.1245/s10434-011-2097-1Authors
		Yuni Elsa Hadisaputri, Department of General Surgical Science (Surgery 1), Graduate School of Medicine, Gunma University, Maebashi, Gunma, JapanTatsuya Miyazaki, Department of General Surgical Science (Surgery 1), Graduate School of Medicine, Gunma University, Maebashi, Gunma, JapanShigemasa Suzuki, Department of General Surgical Science (Surgery 1), Graduate School of Medicine, Gunma University, Maebashi, Gunma, JapanTakehiko Yokobori, Department of General Surgical Science (Surgery 1), Graduate School of Medicine, Gunma University, Maebashi...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5296586</comments>
            <pubDate>Tue, 04 Oct 2011 05:53:26 +0100</pubDate>
            <guid isPermaLink="false">5296586</guid>        </item>
        <item>
            <title>Improving Nodal Harvest in Colorectal Cancer: So What?</title>
            <link>http://www.medworm.com/index.php?rid=5296587&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb387587652tp6252%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;Although improvements in the rate of adequate nodal harvest did occur over time, no corresponding meaningful improvement in
 clinical outcomes was noted. Given the need that quality indicators not only be associated with outcome, but also that outcome
 improves as such indicators are optimized, this study questions the inclusion of a nodal harvest ≥12 lymph nodes as a quality
 indicator of colorectal cancer care.
 
 
 
 
	Content Type Journal ArticleCategory Healthcare Policy and OutcomesPages 1-8DOI 10.1245/s10434-011-2073-9Authors
		Geoffrey A. Porter, Department of Surgery, QEII Health Sciences Centre, Dalhousie University, Halifax, NS, CanadaRobin Urquhart, Cancer Outcomes Research Program, Cancer Care Nova Scotia, Halifax, NS, CanadaJingyu Bu, Cancer Outcomes ...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5296587</comments>
            <pubDate>Tue, 04 Oct 2011 05:53:23 +0100</pubDate>
            <guid isPermaLink="false">5296587</guid>        </item>
        <item>
            <title>Favorable Outcome of Secondary Axillary Dissection in Breast Cancer Patients with Axillary Nodal Relapse</title>
            <link>http://www.medworm.com/index.php?rid=5296588&amp;cid=s_33274_6_f&amp;fid=33274&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft723383684k67366%2F</link>
            <description>Conclusions&amp;nbsp;&amp;nbsp;ALNR is a rare event in treating breast cancer. Young age at diagnosis and medially located tumor are associated with higher
 risk, but standardized initial axillary dissection to level II and adjuvant hormonal therapy is protective against ALNR. In
 patients with ALNR, the outcome is not dismal and survival may be improved if further axillary dissection is given.
 
 
 
 
	Content Type Journal ArticleCategory Breast OncologyPages 1-7DOI 10.1245/s10434-011-2082-8Authors
		Shih-Che Shen, Division of Breast Surgery, Department of General Surgery, Chang Gung Memorial Hospital, Chang Gung University Medical College, Taoyuan, TaiwanChien-Hung Liao, Division of Breast Surgery, Department of General Surgery, Chang Gung Memorial Hospital, Chang Gung University Medical College...</description>
            <author>Annals of Surgical Oncology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5296588</comments>
            <pubDate>Tue, 04 Oct 2011 05:53:22 +0100</pubDate>
            <guid isPermaLink="false">5296588</guid>        </item>
    </channel>
</rss>

